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A B S T R A C T
Background
More than 7.5 million children younger than age five living in low- and middle-income countries die every year. The World Health
Organization (WHO) developed the integrated management of childhood illness (IMCI) strategy to reduce mortality and morbidity
and to improve quality of care by improving the delivery of a variety of curative and preventive medical and behavioral interventions
at health facilities, at home, and in the community.
Objectives
To evaluate the effects of programs that implement the IMCI strategy in terms of death, nutritional status, quality of care, coverage
with IMCI deliverables, and satisfaction of beneficiaries.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 3), including the Cochrane Effective Practice
and Organisation of Care (EPOC) Group Specialised Register; MEDLINE; EMBASE, Ovid; the Cumulative Index to Nursing and
Allied Health Literature (CINAHL), EbscoHost; the Latin American Caribbean Health Sciences Literature (LILACS), Virtual Health
Library (VHL); the WHO Library & Information Networks for Knowledge Database (WHOLIS); the Science Citation Index and
Social Sciences Citation Index, Institute for Scientific Information (ISI) Web of Science; Population Information Online (POPLINE);
the WHO International Clinical Trials Registry Platform (WHO ICTRP); and the Global Health, Ovid and Health Management,
ProQuest database. We performed searches until 30 June 2015 and supplemented these by searching revised bibliographies and by
contacting experts to identify ongoing and unpublished studies.
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Selection criteria
We sought to include randomised controlled trials (RCTs) and controlled before-after (CBA) studies with at least two intervention and
two control sites evaluating the generic IMCI strategy or its adaptation in children younger than age five, and including at minimum
efforts to improve health care worker skills for case management. We excluded studies in which IMCI was accompanied by other
interventions including conditional cash transfers, food supplementation, and employment. The comparison group received usual
health services without provision of IMCI.
Data collection and analysis
Two review authors independently screened searches, selected trials, and extracted, analysed and tabulated data.We used inverse variance
for cluster trials and an intracluster co-efficient of 0.01 when adjustment had not been made in the primary study. We used the GRADE
(Grades of Recommendation, Assessment, Development and Evaluation Working Group) approach to assess the certainty of evidence.
Main results
Two cluster-randomised trials (India and Bangladesh) and two controlled before-after studies (Tanzania and India) met our inclusion
criteria. Strategies included training of health care staff, management strengthening of health care systems (all four studies), and home
visiting (two studies). The two studies from India included care packages targeting the neonatal period.
One trial in Bangladesh estimated that child mortality may be 13% lower with IMCI, but the confidence interval (CI) included no
effect (risk ratio (RR) 0.87, 95% CI 0.68 to 1.10; 5090 participants; low-certainty evidence). One CBA study in Tanzania gave almost
identical estimates (RR 0.87, 95% CI 0.72 to 1.05; 1932 participants).
One trial in India examined infant and neonatal mortality by implementing the integrated management of neonatal and childhood
illness (IMNCI) strategy including post-natal home visits. Neonatal and infant mortality may be lower in the IMNCI group compared
with the control group (infant mortality hazard ratio (HR) 0.85, 95% CI 0.77 to 0.94; neonatal mortality HR 0.91, 95% CI 0.80 to
1.03; one trial, 60,480 participants; low-certainty evidence).
We estimated the effect of IMCI on any mortality measured by combining infant and child mortality in the one IMCI and the one
IMNCI trial. Mortality may be reduced by IMCI (RR 0.85, 95% CI 0.78 to 0.93; two trials, 65,570 participants; low-certainty
evidence).
Two trials (India, Bangladesh) evaluated nutritional status and noted that there may be little or no effect on stunting (RR 0.94, 95%
CI 0.84 to 1.06; 5242 participants, two trials; low-certainty evidence) and there is probably little or no effect on wasting (RR 1.04,
95% CI 0.87 to 1.25; two trials, 4288 participants; moderate-certainty evidence).The Tanzania CBA study showed similar results.
Investigators measured quality of care by observing prescribing for common illnesses at health facilities (727 observations, two studies;
very low-certainty evidence) and by observing prescribing by lay health care workers (1051 observations, three studies; very low-certainty
evidence). We could not confirm a consistent effect on prescribing at health facilities or by lay health care workers, as certainty of the
evidence was very low.
For coverage of IMCI deliverables, we examined vaccine and vitamin A coverage, appropriate care seeking, and exclusive breast feeding.
Two trials (India, Bangladesh) estimated vaccine coverage for measles and reported that there is probably little or no effect on measles
vaccine coverage (RR 0.92, 95% CI 0.80 to 1.05; two trials, 4895 participants; moderate-certainty evidence), with similar effects seen
in the Tanzania CBA study. Two studies measured the third dose of diphtheria, pertussis, and tetanus vaccine; and two measured
vitamin A coverage, all providing little or no evidence of increased coverage with IMCI.
Four studies (2 from India, and 1 each from Tanzania and Bangladesh) reported appropriate care seeking and derived information from
careful questioning of mothers about recent illness. Some studies on effects of IMCI may report better care seeking behavior, but others
do not report this.
All four studies recorded maternal responses on exclusive breast feeding. They provided mixed results and very low-certainty evidence.
Therefore, we do not know whether IMCI impacts exclusive breast feeding.
No studies reported on the satisfaction of mothers and service users.
Authors’ conclusions
The mix of interventions examined in research studies evaluating the IMCI strategy varies, and some studies include specific inputs to
improve neonatal health. Most studies were conducted in South Asia. Implementing the integrated management of childhood illness
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strategy may reduce child mortality, and packages that include interventions for the neonatal period may reduce infant mortality. IMCI
may have little or no effect on nutritional status and probably has little or no effect on vaccine coverage. Maternal care seeking behavior
may be more appropriate with IMCI, but study results have been mixed, providing evidence of very low certainty about whether IMCI
has effects on adherence to exclusive breast feeding.
P L A I N L A N G U A G E S U M M A R Y
Integrated management of childhood illness (IMCI) strategy for children younger than five years of age
What is the aim of this review?
The aim of this Cochrane review is to assess the effects of programs that use the World Health Organization integrated management
of childhood illness (IMCI) strategy. Cochrane researchers searched for all potentially relevant studies and found four studies that met
review criteria.
Key messages
This review shows that use of the World Health Organization IMCI strategy may led to fewer deaths among children from birth to
five years of age. Effects of IMCI on other issues, such as illness or quality of care, were mixed, and some evidence of this was of very
low certainty. In the future, researchers should explore how the IMCI strategy can best be delivered.
What was studied in the review?
More than 7.5 million children globally die each year before reaching the age of five. Most are from poor communities and live in the
poorest countries. These children are more likely than others to suffer from malnutrition and from infections such as neonatal sepsis,
measles, diarrhoea, malaria, and pneumonia.
Effective strategies to prevent and treat sick children are available but do not reach them. One reason for this is that health care services
are often too far away or too expensive. Health facilities in these settings often lack supplies and well-trained health care workers. In
addition, ill children may have several health problems at the same time, and this can make diagnosis and treatment difficult for health
care workers.
In the 1990s, the World Health Organization (WHO) developed a strategy called integrated management of childhood illness (IMCI)
to address these problems. This strategy aims to prevent death and disease while improving the quality of care for ill children up to the
age of five. It consists of three parts.
• Improving the skills of health care workers by providing training and guidelines.
• Improving how health care systems are organized and managed, including access to supplies.
• Visiting homes and communities to promote good child rearing practices and good nutrition, while encouraging parents to bring
their children to a clinic when the children are ill.
The WHO encourages countries to adapt the IMCI strategy to their own national settings. Types of childhood illnesses prioritised and
ways in which services are delivered may vary from country to country.
What are the main results of the review?
This Cochrane review included four studies assessing the effectiveness of the IMCI strategy. These studies were conducted in Tanzania,
Bangladesh, and India. The IMCI strategy was used very differently across studies. For instance, the study from Tanzania implemented
health care worker training and improved drug supply but did not include home visits or community activities; the study from
Bangladesh added new health care workers while training existing health care workers; and the two Indian studies specifically targeted
newborns as well as older children.
This review showed that use of IMCI:
• may lead to fewer deaths among children from birth to five years of age (low-certainty evidence);
• may have little or no effect on the number of children suffering from stunting (low-certainty evidence);
• probably has little or no effect on the number of children suffering from wasting (moderate-certainty evidence);
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• probably has little or no effect on the number of children who receive measles vaccines; and
• may lead to mixed results on the number of parents seeking care for their child when he or she is ill.
We do not know whether IMCI has any effect on the way health care workers treat common illnesses because certainty of the evidence
was assessed as very low.
We do not know whether IMCI has any effect on the number of mothers who exclusively breast feed their child, because certainty of
the evidence was assessed as very low.
None of the included studies assessed the satisfaction of mothers and service users by using an IMCI strategy.
How up-to-date is this review?
Review authors searched for studies that had been published up to 30 June 2015.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Patient or population: children < 5 years of age
Settings: middle- and low-income countries
Intervention: integrated management of childhood illness
Comparison: usual health services
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Assumed risk Corresponding risk
Control IM CI
M ortality Child mortality Risk ratio 0.87a
(0.68 to 1.10)
5090 children
(1 trial)1
⊕⊕©©
Lowb,c
due to indirectness and
imprecision
Child mortality may be
decreased, but conf i-
dence intervals include
no ef fect
31 per 1000 live births 27 per 1000 live births
(21 to 34)
Infant mortality HR 0.85
(0.77 to 0.94)
60,480e
(1 trial) 2
⊕⊕©©
Lowf,g,h
due to indirectness and
imprecision
Infant mortality may de-
crease
69 per 1000 live births 59 per 1000 live births
(54 to 65)d
Nutritional status Stunting Risk ratio 0.94 i
(0.84to1.06)
5242
(2 trials) 1,2
⊕⊕©©
Lowb,f,j
due to indirectness and
imprecision
Lit t le or no ef fect on
stunt ing possible
57 per 100 53 per 100
(48 to 60)
Wasting Risk ratio 1.04 i
(0.87 to 1.25)
4288
(2 trials) 1,2
⊕⊕⊕©
M oderate b,j
due to indirectness
Probably lit t le or no ef -
fect on wast ing
13 per 100 14 per 100
(11 to 16)
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Quality of care Prescribing at health facilities Mixed ef fectsk 727
(2 studies)1,3
⊕©©©
Very lowl,m
due to imprecision, in-
consistency, and indi-
rectness
Not known whether
consistent ef fect on
prescribing quality at
health facilit ies
Prescribing by lay health care workers No consistent ef fects 1051 observat ions
(3 studies)1,3,4
⊕©©©
Very lowl,m
due to imprecision, in-
consistency, and indi-
rectness
Not known whether
consistent ef fect on
prescribing quality of
lay health care workers
Coverage of IM CI de-
liverables
Vaccine coverage (measles) RR 0.92
(0.80 to 1.05)
4895
(2 trials) 1,2
⊕⊕⊕©
M oderaten,j
due to indirectness
Probably lit t le or no ef -
fect on measles vac-
cine coveragen
57/ 100 54/ 100
(46 to 60)
Supplement coverage (vit A) RR 0.93
(0.88 to 0.98)
831
(1 trial)1
⊕⊕⊕©
moderaten,j
due to indirectness
Probably lit t le or no ef -
fect on vitamin A cover-
age
83 per 100 77 per 100
(73 to 81)
Appropriate care seeking Mixed ef fectso 4182
(3 studies)1,2,3
⊕⊕©©
Lowp
due to inconsistency
Appropriate care seek-
ing possibly improved
in some studies, but not
in others
Exclusive breast feeding Mixed ef fectsq 7975
(4 studies) 1,2,3,4
⊕©©©
Very lowp,r,s,t,u
due to indirectness and
inconsistency
Not known whether ef -
fect on exclusive breast
feeding
Satisfaction of benefi-
ciaries
Not measured Not known whether
users prefer IMCI or
usual clinics
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The basis for assumed risk is median control group risk across studies. The corresponding risk (and its 95% conf idence interval) is based on assumed risk in the comparison
group and relative effect of the intervent ion (and its 95% CI)
CI: conf idence interval; ICC: intracluster correlat ion co-ef f icient; RR: risk rat io
GRADE Working Group grades of evidence
High certainty: We are very conf ident that the true ef fect lies close to the est imate of ef fect
M oderate certainty: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of ef fect but may be substant ially dif f erent
Low certainty: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of ef fect
Very low certainty: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
a In the Bangladesh trial, mortality declined over the 5 years f rom 43 per 1000 live births to 27 per 1000 live births in the
intervent ion area (reduced by 37%), and f rom 44.8 per 1000 live births to 31.2 per 1000 live births in control areas (reduced
by 30%). A small dif f erence in the reduct ion in child mortality was noted in the 2 groups (8.6% in the intervent ion group vs
7.8% in control groups).
The Tanzanzia CBA study had mortality est imates that were very sim ilar to the Bangladesh trial (RR 0.87, 95%CI 0.72 to 1.05).
bDowngraded by 1 for serious indirectness: The Bangladesh trial modif ied the intervent ion af ter early analysis for care seeking
and referral complet ion, suggest ing that coverage was not increasing as expected. This included modif icat ion of treatment
and referral guidelines and introduct ion of a new cadre of village health care workers trained and equipped to provide
community case management for pneumonia and diarrhoea in 2005. These adjustments, including the new staf f cadre, were
in response to an intermediate process evaluat ion in the trial, and are unlikely to be mirrored in rout ine implementat ion
programmes.
cDowngraded by 1 for imprecision: 95% CI is wide and includes a clinically important reduct ion in mortality and no ef fect. In
addit ion, dominant change was secular (see note 1)
dAbsolute rates were calculated f rom hazard rat io by using the formula RR = (1 - exp(HR ×ln(1 - assumed risk)))/assumed risk
eIMCI in this trial included perinatal and neonatal components
f Downgraded for serious imprecision. Conf idence intervals include no important ef fect to an important ef fect
gDowngraded by 1 for serious indirectness: This single study was conducted in a mixed rural/ urban populat ion in northern
India with a substant ive neonatal component with home visit ing. Findings may not be easily generalized to other sett ings in
Asia or elsewhere
hSubgroup analysis showed lower mortality in the intervent ion group among babies delivered at home, with no ef fect apparent
in the subgroup delivering at hospital. This subgroup ef fect was evident for both neonatal and infant mortality
iConf idence intervals for Arifeen adjusted assuming ICC of 0.01
j The Tanzania CBA study has very sim ilar est imates compatible with this est imate
kLarge improvements in 6 parameters in Arifeen; no clear ef fect in 2 parameters in Schellenberg
lDowngraded by 1 for both imprecision and inconsistency. Small numbers of part icipants observed; ef fect varies between
trials and parameters measured
mDowngraded by 1 for indirectness. All measurements through direct observat ion of health care worker; may not represent
behavior unobserved7
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nDowngraded by 1 for indirectness. Approximately 80% of the est imate taken f rom 1 study, so generalisability to other sett ings
is uncertain
oPoint est imate for vaccine coverage suggests higher coverage in control group, and 95% conf idence intervals exclude
benef icial ef fect of IMCI on coverage.
pThis outcome was measured in various ways by dif ferent studies on samples of pat ients. Large improvements noted in
some studies but not in others. As the outcome was so varied, we did not prepare a meta-analysis
qDowngraded by 2 for inconsistency. Some large ef fects in some studies, and modest/ no ef fects in others
r Mixed ef fects between the 4 studies preclude meta-analysis
sDowngraded by 2 for inconsistency. Large amounts of qualitat ive heterogeneity
t Downgraded by 1 for indirectness. See (b) above and the large ef fects seen in Bhandari associated with several home visits,
which would not be feasible in other sett ings
uDowngraded by 1 for risk of bias. Breast feeding was reported through quest ionnaire f rom health care workers to mothers
Studies
1 Arifeen 2009;2 Bhandari 2012; 3 Schellenberg 2004 ; 4 Mohan 2011
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B A C K G R O U N D
Description of the condition
More than 7.5million children globally die each year before reach-
ing the age of five. Most of these deaths occur in low- and middle-
income countries (LMICs) (Black 2003; Liu 2012), where inter-
action of common infections (including neonatal sepsis, measles,
diarrhoea, malaria, and pneumonia) with poor nutritional status,
combined with inadequate health infrastructure and poverty, re-
sults in poor health outcomes (Liu 2012; Tulloch 1999). Statis-
tical projections over the past decade suggest that these common
childhood illnesses will continue to be major contributors to the
child morbidity and mortality burden until 2020 (Murray 1996).
These projections have been uncannily accurate, as shown by re-
cent mortality data (WHO 2012), providing a strong case for in-
troducing new strategies to tackle problems contributing to poor
outcomes.
In addition to overall high child mortality globally, there are large
differences in mortality between countries, with earlier studies in-
dicating that 95% of global mortality happens in 42 less-devel-
oped countries (Victora 2003); there are also differences in mor-
tality between socio-economic groups within countries. Children
who belong to the more underprivileged sections of society are
more likely to suffer from malnutrition and to experience greater
severity of illness and highermortality (Black 2003; Victora 2003).
These inequalities are reflected in the quality of health care re-
ceived. Studies have shown that at first-level health facilities in
LMICs, assessment by health care workers is poor, treatment facil-
ities are inadequate, and parents receive improper advice (Barros
2012; World Health Organization 1998).
Providing quality care to sick children in LMICs is important.
Effective and affordable interventions have been known to reduce
childhood morbidity and mortality for some time, but their avail-
ability, accessibility, and acceptability to the ultimate beneficiaries
have been unacceptably low (Bryce 2003; Jones 2003).
Description of the intervention
Individual health interventions shown to be effective in reducing
child mortality include exclusive breast feeding, improved vac-
cination coverage, oral rehydration therapy, pneumonia therapy,
and early treatment for malaria in endemic areas (Bhutta 2008;
Markowitz 1991; Mathew 2011; Thwing 2011). However, chil-
dren presenting to first-level health facilities seldom present with
a single ailment. The presence of multiple and overlapping mor-
bidities makes diagnosis and treatment difficult for the health care
worker. Although each of these interventions has been individu-
ally shown to be effective, it has gradually become clear to health
care planners that a more integrated approach is needed to achieve
better outcomes. This has resulted in a policy push toward a multi-
pronged strategy aimed at integrating improved health care ser-
vices with better case management skills and healthier community
practices to reduce child mortality and morbidity (WHO 1996).
Health care packages that aim to integrate these components of
health care strategy have been designed and implemented at com-
munity, national, and international levels. In the mid-1990s, the
World Health Organization (WHO), in collaboration with the
United Nations Children’s Emergency Fund (UNICEF) and other
agencies, developed a strategy known as integrated management
of childhood illness (IMCI) in response to these challenges.
The IMCI strategy includes both curative and preventive inter-
ventions targeted at improving health practices at health care facil-
ities, at home, and in the community. This strategy includes three
main components (Tulloch 1999): (1) improvement in the case
management skills of health care staff through provision of locally
adapted guidelines on IMCI and activities to promote their use;
(2) improvement in the overall health care system required for ef-
fective management of childhood illnesses; and (3) improvement
in family and community health care practices.
In 1995, WHO technical programs and partners, supported by
sound research, introduced case management guidelines for IMCI
(WHO 1997), with a core intervention targeting five of the most
important causes of child mortality: acute respiratory infection
(ARI), diarrhoea, measles, malaria, and malnutrition. The follow-
ing year, a training program was targeted at first-level health care
workers. These case management guidelines were adapted to local
epidemiology and clinical practice, and training of the first health
care workers started in 1995. This was followed by a short period of
exploratory implementation and documentation in a small num-
ber of countries (Lambrechts 1999). After an initial pilot phase,
IMCI was introduced in Tanzania and Uganda in 1996 (Bryce
2005). Results from these two countries were encouraging, with
improvements noted in quality of care and health care worker prac-
tices (Lambrechts 1999). In the early phase of its implementation,
IMCI was focused on training health care workers, with less at-
tention paid to the other two components, namely, strengthening
health care systems and improving community practices. Initial
guidelines and training materials were considered appropriate for
countries with an infant mortality rate greater than 40/1000 live
births, and with documented transmission of Plasmodium falci-
parummalaria. The guidelines and training materials represented
an attempt to outline what needed to be done at a first-level health
facility by any healthworker - doctor, nurse, or paramedical worker
- seeking to treat sick children while reducing mortality.
Upon receipt of an encouraging response from partner organi-
zations, various countries, and the World Bank, the WHO pro-
vided a detailed blueprint of a three-phase rollout for countries
wishing to adopt IMCI (WHO 1999). The process consisted of
the introduction phase, the early implementation phase, and the
expansion phase. The purpose of the introduction phase is to en-
sure that policymakers understand IMCI. This involves initiating
contact to provide information, holding orientation meetings, and
9Integrated management of childhood illness (IMCI) strategy for children under five (Review)
Copyright © 2016 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
building national capacity in IMCI. In the early implementation
phase, health care staff conduct and monitor IMCI activities in a
limited number of districts to study impact. Other issues studied
during this phase include the relationship of IMCI to other health
care sector activities, drug availability, and policy and supervision.
The expansion phase involves increasing access to interventions
introduced in the first two stages. The WHO and collaborating
agencies provide technical assistance in preparation for early im-
plementation of IMCI.
Anecdotal data, qualitative reviews, and systematic reviews from
various countries suggest that IMCI has been effective in improv-
ing health service quality and increasing health care cost savings
(Ahmad 2010; Amaral 2008). Since its introduction, IMCI has
been taken up by numerous countries, initially as a pilot project,
and later as a national program. The three components of IMCI
have been implemented in various ways in different countries. Key
features of IMCI include its evidence-based approach to diagno-
sis and treatment and its flexibility in terms of adapting guide-
lines to local epidemiological situations. The adaptation process
involves detailed comparisons of existing guidelines in a coun-
try with IMCI and application of the most effective components
of both. Consensus is needed on the conditions that should be
covered. Malaria can be removed from guidelines in which falci-
parum malaria is not a problem. Other countries have included
dengue fever as an important problem. IMCI has already been
adapted to include the neonatal period, and some countries, like
India, have incorporated neonatal care in implementation of the
program. Selection of antibiotics for ARI and diarrhoea is based
on local sensitivity patterns and availability. Some countries have
shortened the duration of training to reduce costs. In many coun-
tries, especially in sub-Saharan Africa, HIV/AIDS contributes sig-
nificantly to child morbidity and mortality, resulting in the need
to include specific assessment and management of symptomatic
HIV infection in IMCI guidelines. A draft HIV component of the
IMCI guidelines, which included management of symptomatic
HIV cases with referral for counselling and testing, was evaluated
in South Africa. A revised version was then validated in Ethiopia
and Uganda, where prevalence of HIV, malnutrition, and malaria
is different from South Africa. IMCI materials were then adapted
to include an HIV component (Qazi 2006). The WHO has for-
mulated anAdaptationGuide to describe the process of adaptation
by a country and facilitate continuous evolution of the program
(WHO 1999a).
Large-scale rollout and continuation of IMCI require money. In
several countries, external donors have largely funded IMCI imple-
mentation. Within 10 years, donor support began to wane, leav-
ing health departments of poor countries with inadequate funds
(Duke 2009). Indeed the places where IMCI is needed most, and
in which it provides the greatest impact, are those in which the
health care system is weakest and implementation of the strategy
often fades. Therefore, it is important to ensure adequate develop-
ment along with the introduction of newer innovations. A global
study conducted across 27 countries cited high cost as a major
challenge to scaling up of the program (Goga 2011). Apart from
modifications such as shortening of training duration, new tech-
nology such as the IMCI computerized adaptation and training
tool (ICATT) is being introduced. Trials are currently under way
to assess the effectiveness of these tools.
How the intervention might work
The IMCI clinical guidelines target children up to five years of
age - the age group that bears the greatest burden of death from
common childhood diseases. These guidelines are derived from
an evidence-based, syndromic approach to case management and
emphasize rational, effective, and affordable use of drugs and diag-
nostic tools (Gove 1997; Hill 2004).With well-formulated guide-
lines and proper training of health care workers, it would be possi-
ble to systematically assess common symptoms and clinical signs,
ultimately leading to rational and effective actions. Such an ap-
proach can help in diagnosing the clinical condition, assessing the
severity of the condition, and implementing actions that can be
taken to care for the child (e.g. refer the child immediately,manage
within available resources, manage at home).
Initially, IMCI referred to case management of children. It later
became a vehicle for WHO and UNICEF child survival strategies
at household, community, health facility, and referral levels. Thus
it incorporated health service strengthening on the one hand and,
on the other hand, face-to-face nutrition and health advice pro-
vided through home visits and active involvement of family mem-
bers and the community in the health care process (Gove 1997;
Hill 2004). Thus, over the years, implementation of IMCI, called
the IMCI strategy, has come to include three components.
• Training component: training of health care workers in
clinical care with the use of IMCI guidelines.
• Systems component: investment in health care systems
organization and management, including supplies, related
specifically to delivery of IMCI.
• Community health component: Auxiliary health care staff
and community health care workers attached to clinics conduct
home visits and community health promotion to promote good
child rearing practices, good nutrition, and access to services
when the child is ill (Hill 2004).
Why it is important to do this review
Currently, more than 75 countries are implementing the IMCI
strategy on a large scale. For years, individual aspects of child
health, often contained within trials evaluating the efficacy of
one intervention, have been carried out, for example, in vitamin
A supplementation. Individual components of IMCI have often
been tested and have proved effective in rigorously conducted ran-
domised controlled trials and systematic reviews. However, it is
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unclear whether delivery of this package impacts hard outcomes
such asmortality. As provision of IMCI is expensive, solid evidence
of an impact on child health contributes to continued provision of
political and financial support of this comprehensive child health
strategy.
Global evaluation of IMCI, called “the multi-country evaluation
of IMCI,” was started in the early 1990s to generate informa-
tion on effectiveness, cost, and impact, alongside other initiatives,
such as the IMCI evaluation by the Centers for Disease Con-
trol and Prevention (CDC) (Schellenberg 2004); investigators re-
ported across five study sites (WHO 2002). Other reviews have
described health care worker performance as the primary outcome
indicator (Amaral 2008) or have assessed the impact of the du-
ration of training for IMCI (Rowe 2008), thereby not analysing
the impact of the intervention on beneficiaries. A comprehensive
systematic review is therefore required to evaluate the effectiveness
of IMCI in improving child health (as measured by mortality or
nutritional status), its impact on the quality of care delivered, and
whether basic healthy practices delivered by caregivers improve.
O B J E C T I V E S
To evaluate the effects of programs that implement the integrated
management of childhood illnesses (IMCI) strategy in terms of
death, nutritional status, quality of care, coverage with IMCI de-
liverables, and satisfaction of beneficiaries.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials, including cluster-randomised trials.
Non-randomised trials with a concurrent comparison group (no
IMCI intervention) and adjustment for baseline characteristics
and confounders.
Controlled before-after (CBA) studies in which allocation to dif-
ferent comparison groups was not made by study investigators,
and outcomes were measured in both intervention and control
groups at baseline and after the IMCI program had been intro-
duced.
All studies required at least two intervention sites and at least two
control sites.
Types of participants
The unit of study was primary health care services in low- and
middle-income countries (as categorized by The World Bank us-
ing gross national income per capita in US dollars and the Atlas
conversion factor (World Bank 2012)). This could be provided by
the public, private, or non-government agency sector.
Participants were children younger than five years of age and health
care providers in low- andmiddle-income countries (as categorized
by The World Bank using gross national income per capita in US
dollars and the Atlas conversion factor (World Bank 2012)).
Types of interventions
Children younger than five years of age allocated to receive the
generic WHO/UNICEF IMCI intervention or its adaptation. To
be included, the IMCI intervention needed to include improving
health care worker skills for case management as one component.
We included studies of (1) IMCI training alone; (2) IMCI training
plus systems interventions to improve care delivery; (3) IMCI
training with additional activities to improve community health
practices; and (4) all three interventions.
We excluded studies that included IMCI only as a part of a wider
intervention package that could include conditional cash transfers,
food supplementation, employment, and vertical disease-specific
measures.
Studies providing specific additional interventions in both inter-
vention and control areas were eligible for inclusion as long as
these additional interventions were similar across intervention and
control areas.
Comparison
We included studies in which the comparison group received usual
health services without the integrated health care package (IMCI).
Types of outcome measures
• Measures of mortality (neonatal, infant, and under-five
mortality) rates.
• Measures of nutritional status, including stunting and
wasting.
• Quality of care assessed by adherence to standard practice
guidelines.
• Coverage of key IMCI deliverables, including (1) vaccine
coverage; (2) appropriate care seeking for common illnesses; and
(3) exclusive breast feeding.
• Satisfaction of beneficiaries.
As one study also reported on other newborn care practices, which
we did not anticipate, we describe these results under “coverage.”
In addition, in the protocol, we stated that we would assess mor-
bidity episodes as secondary outcomes. As it is unlikely that IMCI
would influence the incidence of disease, and studies did not re-
port on this, we have not commented further on this outcome.
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Search methods for identification of studies
Electronic searches
We attempted to identify all relevant trials irrespective of language
or publication status. We used the search term “IMCI” OR “IM-
NCI” OR “integrated management of childhood illness” across
various databases. Amore complex search strategy was not needed,
as “IMCI” does not have a corresponding medical subject heading
(MeSH) term, and all papers that consider IMCI use this term in
the title, abstract, or text.
We (TG and DS) searched the following databases using the strat-
egy described above.
• Cochrane Central Register of Controlled Trials
(CENTRAL) (www.cochranelibrary.com), including the
Cochrane Effective Practice and Organisation of Care (EPOC)
Group Specialised Register (searched 30 June 2015).
• MEDLINE (1946 to date), Ovid (searched 30 June 2015).
• EMBASE (1980 to date), Ovid (searched 30 June 2015).
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL) Plus (2000 to date), EbscoHost (searched 30 June
2015).
• Latin American Caribbean Health Sciences Literature
(LILACS), Virtual Health Library (VHL) (searched 30 June
2015).
• World Health Organization (WHO) Library &
Information Networks for Knowledge Database (WHOLIS)
(searched 30 June 2015).
• Science Citation Index and Social Sciences Citation Index,
Institute for Scientific Information (ISI) Web of Science (1950
to present) (searched 30 June 2015).
• Population Information Online (POPLINE) (searched 30
June 2015).
• World Health Organization (WHO) International Clinical
Trials Registry Platform (WHO ICTRP) (searched 30 June
2015).
• Global Health (1973 to 2016 Week 17), OvidSP (searched
08 May 2016).
• Health Management (1986 to present), ProQuest (searched
to 17 December 2012. We did not have access to this database
after this date).
We have listed in Appendix 1 search strategies used for the various
databases and the number of trials identified.
Searching other resources
We scanned the reference lists of all included papers and relevant
reviews to identify citations that could have been missed in the
primary search. We contacted authors of other relevant reviews in
the field regarding relevant studies of which they were aware.
Data collection and analysis
Selection of studies
Two review authors (TG and DS) removed duplicate records, then
independently scanned the titles and abstracts of studies identi-
fied in the computerized search to exclude literature that clearly
did not meet the inclusion criteria. We examined full-text articles
against eligibility criteria while using a structured form. We re-
solved uncertainties about inclusion by discussion and consensus
between all review authors. Controlled before-after studies were
required to include at least two control groups and at least two
intervention groups, as otherwise differences detected are totally
confounded by study site.
Data extraction and management
Two review authors (TG and DS) used a structured form to in-
dependently extract relevant data, including details of methods,
participants, setting, context, interventions, outcomes and results,
publications, and investigators. We resolved discrepancies by mu-
tual discussion. When discrepancies could not be resolved, we
sought assistance from a third review authors (HSS).
We described the IMCI strategy by using a matrix to detail inputs
and activities. This matrix includes (1) training inputs; (2) tools
and manuals, including guidelines; (3) additional equipment and
drugs provided; (4) managerial supervision and monitoring, in-
cluding additional health information collected; and (5) engage-
ment, training, and support of community volunteers, as well as
health care providers involved in the program. We intended to
stratify the analysis to reflect inputs (separating simple training;
training and systems support; training and community engage-
ment; and training, systems support, and community engagement)
but found that data were insufficient.
Assessment of risk of bias in included studies
Two review authors (TG and DS) independently assessed the risk
of bias for each controlled trial and controlled before-after study
using criteria outlined in theCochrane Handbook for Systematic Re-
views of Interventions and those recommended by EPOC (EPOC
2015; Higgins 2011). For randomised controlled trials, non-ran-
domised controlled trials, and CBA studies, these criteria include
the following.
• Sequence generation (selection bias).
• Allocation sequence concealment (selection bias).
• Blinding of participants and personnel (performance bias).
• Blinding of outcome assessment (detection bias).
• Incomplete outcome data (attrition bias).
• Selective outcome reporting (reporting bias).
• Comparability of baseline outcome and characteristics.
• Protection from contamination.
• Other potential sources of bias.
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For cluster-randomised trials, particular biases to consider include
the following.
• Recruitment bias.
• Baseline imbalance.
• Loss of clusters.
• Incorrect analysis.
We omitted “comparability with individually randomised trials”,
as this intervention could be tested only in the context of a cluster
trial (Higgins 2011).
The judgment for each entry involves assessing risk of bias as
“low,” “high,” or “unclear,” with the last category indicating lack of
information or uncertainty over the potential for bias. We resolved
disagreements by discussion between review authors.
Measures of treatment effect
We expressed results as risk ratios (RRs) with 95% confidence in-
tervals (CIs) for binary outcomes. We analysed continuous out-
comes using mean differences (MDs).
Unit of analysis issues
When a cluster-randomised trial was adjusted for clustering, we
extracted cluster-adjusted results and used them in analyses.
When a cluster-randomised trial did not adjust for clustering, we
extracted unadjusted results. As we were not able to obtain an
estimate of intracluster correlation co-efficients (ICCs) from the
trials themselves, we used sensitivity analyses and an estimated
ICC of 0.01 to investigate the impact of clustering on estimates
of effectiveness.
Dealing with missing data
We anticipated that we would need to impute values to estimate
cluster effects, but this was not required.
Assessment of heterogeneity
We described the context in which the intervention was imple-
mented. We described in the table of included studies variability
among participants, interventions, and outcomes studied.
Statistical heterogeneity was to be identified and measured as rec-
ommended by the Cochrane Handbook for Systematic Reviews of
Interventions (Section 9.5.2) (Higgins 2011). As we found so few
studies, we were careful about conducting meta-analysis and car-
ried this out only when it made sense to do so. If heterogeneity
based on Chi2 was assessed as greater than 50%, we used a ran-
dom-effects model and interpreted results carefully.
Assessment of reporting biases
We anticipated using funnel plots to examine for publication bias
but found insufficient trials to do this.
Data synthesis
Overall, the review provides a structured synthesis. When meta-
analysis made sense, we used Review Manager software (RevMan
5.3), expressing results as risk ratios with 95%confidence intervals,
or mean differences, as applicable. We used CBA results along-
side the trials results, but did not combine them statistically. We
assessed the certainty of the evidence by using the GRADE ap-
proach and summarized key findings in Summary of findings for
the main comparison.
Subgroup analysis and investigation of heterogeneity
Our planned subgroup analyses were not possible, as data were
insufficient.
R E S U L T S
Description of studies
Results of the search
Searches of various databases yielded 1499 records to be screened,
after duplicates were deleted. Of these, we found 1433 irrelevant
to the review on screening. We obtained full texts of the remain-
ing 50 studies, reported in 66 publications. Of these, four stud-
ies (two cluster RCTs and two CBA studies) described in 12 ar-
ticles met our inclusion criteria (Figure 1). We reported reasons
for excluding studies in the Characteristics of excluded studies ta-
ble. We identified one trial through other sources in May 2016
(Boone 2016). We included this study amongst Studies awaiting
classification and will consider it in an update in due course.
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Figure 1. Study flow diagram.
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Included studies
Locations and populations
Studies were conducted in Tanzania (data collection from 1997
to 2002), Bangladesh (1999 to 2007), and India (2006 to 2010).
One analysis was obtained from India’s national program (2005
to 2009).
Schellenberg 2004 was carried out in four rural districts of Tan-
zania, with two intervention clusters and two control clusters that
were geographically contiguous and matched for mortality rates.
Arifeen 2009 was conducted in Bangladesh, in areas of a subdis-
trict where the sampling frame consisted of first-level outpatient
facilities. Bhandari 2012 was carried out in primary care health
centres within a single district of a state in Haryana, India. In a
second study from India, Mohan 2011 collected data from 12 dis-
tricts of India that had initiated IMCI and compared them with
data from matched control districts.
Strategies
Interventions are summarized as an input matrix (Table 1) related
to human resource policies, health systems strengthening, and
strategies for community engagement. Trials varied substantially
in range of inputs provided. The earliest trial comprised two IMCI
components: training for basic health care workers, and drug sup-
ply combined with tools and manuals (Schellenberg 2004).
Arifeen 2009 included training of basic health care workers but
provided more substantive supervision, health service strength-
ening, and strategies for community engagement. Investigators
added a new cadre of health worker halfway into the study for
treatment of community pneumonia and diarrhoea.
Bhandari 2012 included training of all cadres of health care work-
ers consisting of human resource management strategies, drug
supply, and community engagement, including support to village
doctors, women’s groups, and women’s leaders.
Mohan 2011 reported fewer inputs than Bhandari 2012 but in-
cluded home visits and drug supply.
The two trials in India (Bhandari 2012; Mohan 2011) modified
the IMCI package to include a series of interventions specifically
targeted at the neonate. These interventions were defined in the
IMNCI guidelines by the Government of India (WHO 1998;
WHO 2003).
Details of the interventions are included inTable 2. Routine health
care was used for comparison in all trials.
Study design
Two studies were cluster-randomised trials (Arifeen 2009;
Bhandari 2012); two were controlled before-after studies (Mohan
2011; Schellenberg 2004). Both cluster RCTs used appropriate
methods to take clustering into account when reporting measures
of treatment effect.
Outcomes
Arifeen2009 reportedmortality in children younger thanfive years
of age, while excluding death in the first week of life. Schellenberg
2004 reported under-five mortality rates at baseline and at two
years after implementation of IMCI. Bhandari 2012 reported
neonatal mortality, neonatal mortality beyond the first 24 hours
of birth, and infant mortality.
In Arifeen 2009, in the abstract of the article but not in the main
text, study authors reported on the percentage difference in mor-
tality rates in the last two years of the study (27.0/1000 in the IMCI
group, 31.2/1000 in the control group). This is not corrected for
baseline (which is lower in the IMCI group), thus this estimate is
inflated. We calculated absolute differences in death between the
two groups in Summary of findings for the main comparison, as
these data are more informative.
For nutritional status, three studies reported wasting and stunting
(Arifeen 2009; Bhandari 2012; Schellenberg 2004).
For quality of care, Arifeen 2009 reported on health facility readi-
ness and quality of assessment and treatment of sick children.
For coverage of key IMCI deliverables, studies included the fol-
lowing.
• All studies reported on measles immunization coverage.
• Studies reporting appropriate care seeking used different
approaches
• All studies reported on exclusive breast feeding but at
different time points: four weeks (Bhandari 2012); four months
(Schellenberg 2004); and six months (Arifeen 2009; Mohan
2011). Other outcomes are listed in the Characteristics of
included studies table.
No study reported satisfaction of mothers and service users.
Funding
Arifeen 2009 and Schellenberg 2004 were included in the Multi-
Country Evaluation of IMCI Effectiveness, Cost, and Impact
(MCE), which was co-ordinated by the Department of Child and
AdolescentHealth andDevelopment ofWHO.TheWorldHealth
Organization funded Bhandari 2012. No source of funding was
given for Mohan 2011, but three study authors were (at the time
of publication) affiliated with WHO or UNICEF.
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Excluded studies
The Characteristics of excluded studies table summarizes the rea-
sons why studies were excluded. Of the 45 studies (53 reported
papers):
• we excluded three, as they had just one intervention and
control cluster (Atakuoma Dzayisse 2006; Esaghi 2012; Rowe
2011);
• we excluded five, as the outcome was not of interest (Adam
2009; Gilroy 2004; Kelley 2001; Mahalli 2011; Prado 2006);
• we excluded 14, as a component of the IMCI was
implemented but not the complete generic WHO IMCI (Ali
2005, Ebuehi 2009; Ebuehi 2010; Ertem 2006; Gebresellasie
2011; Ghimire 2010; Hamad 2011; Harkins 2008; Igarashi
2010; Jin 2007; Pelto 2004; Santos 2001; Talsania 2011; Zaman
2008);
• we excluded 16, as they did not include a control group
(Camara 2008; Chopra 2005; Chowdhury 2008; Core Group
2009; Edward 2007; Huicho 2005; Huicho 2008; Kumar 2009;
Mohan 2004; Pariyo 2005; Rakha 2013; Senn 2011; Thompson
2009; Uzochukwu 2008; Wammanda 2003; Zhang 2007). In
addition, the control group had partial rollout of the IMCI
program in one trial (Moti 2008); and
• we excluded one of the remaining studies as it was a cross-
sectional survey with no baseline data and therefore did not
qualify as a CBA trial (Naimoli 2006). Three publications were
narrative reviews pertaining to IMCI that presented no data
(Almagambetova 2000; Lulseged 2002; Oluwole 2000), and one
was a secondary analysis of data (Gouws 2004). One trial
assessed improvements to IMCI with addition of special
“supports” (Osterholt 2009). Two trials did not pertain to IMCI
and were obviously irrelevant (Bradley 2005; Zurovac 2006).
Risk of bias in included studies
See Figure 2 and Figure 3 for summaries of risk of bias, and the
Characteristics of included studies table for details of risk of bias
and methods used in each trial. Arifeen changed the intervention
when care seeking and referral completion did not turn out as
expected. This impacted the indirectness and generalisability of
the trial.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Effects of interventions
See: Summary of findings for the main comparison Integrated
management of childhood illness strategy compared with routine
care
Mortality
Three studies summarized in Table 3 reported effects of IMCI on
mortality.
Child mortality
One trial and one CBA evaluated this. The Bangladesh trial esti-
mated that child mortality may be 13% lower in the IMCI group,
but the confidence intervals include no effect (RR 0.87, 95% CI
0.68 to 1.10, 5090 participants, low-certainty evidence). The Tan-
zania CBA study produced very similar estimates (RR 0.87, 95%
CI 0.72 to 1.05). (Analysis 1.1).
In the Bangladesh trial, it is important to note that mortality in
both intervention and control groups fell markedly over the six-
year period. When the first two years were compared with the last
two years, the rate fell from 70.0 to 49.3/1000 live births in the
IMCI group, and from 65.6 to 50.5/1000 live births in the con-
trol group, but investigators detected no differences between in-
tervention and control groups. Study authors reported that IMCI
group mortality was slightly lower by 3.3% (95% CI -3.4 to 10.0,
adjusted for baseline imbalance), but the estimate includes a null
effect (Arifeen 2009).
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Infant and neonatal mortality
Bhandari 2012, who included a neonatal component to IMCI, re-
ported data on these outcomes, adjusted for potential confounders
(Table 3). The infant mortality hazard ratio (HR) suggests that
infant mortality may be lower in the IMNCI group than in the
control group (cluster-adjusted HR 0.85, 95% CI 0.77 to 0.94;
low certainty of evidence; Analysis 1.1), although neonatal effects
were marginal and confidence intervals included no effect (clus-
ter-adjusted HR 0.91, 95% CI 0.80 to 1.03; Analysis 1.1). In a
subgroup analysis, the neonatal mortality rate was lower in IMCI
clusters in the subgroup delivered at home (cluster-adjusted HR
0.80,95% CI 0.68 to 0.93) but not in those delivered at a health
facility (cluster-adjusted HR 1.06, 95% CI 0.91 to 1.23). This
subgroup effect was preserved for infant mortality (home deliver-
ies, cluster-adjusted HR 0.77, 95% CI 0.69 to 0.87; facility-based
deliveries, cluster-adjusted HR 0.98, 95%CI 0.87 to 1.10). Study
authors attributed the difference in mortality to more effective
change in newborn care practices (including early breast feeding,
exclusive breast feeding, delayed bathing, appropriate cord care)
among home born babies compared with those delivered at the
facility. The intervention may have improved timely seeking of
health care for sick newborns, thereby affecting neonatal and in-
fant mortality.
In a subsidiary analysis, we examinedmortality among participants
younger than five years of age, conducting a meta-analysis that
combined child mortality with infant mortality. This post hoc
analysis was justified on the basis that infant mortality accounts
for 70% of under-five mortality (Analysis 1.2). Overall, under-
five mortality may be reduced by IMCI (RR 0.85, 95% CI 0.78
to 0.93; two trials; 65,570 participants).
Nutritional status
Three studies assessed nutritional status; we have summarized their
findings in Table 4 (Arifeen 2009; Bhandari 2012; Schellenberg
2004). Published data from Arifeen 2009 were not cluster-ad-
justed, so we used an ICC of 0.01 in the meta-analysis (see
Methods).
For stunting, all confidence intervals overlap, and we considered
it not unreasonable to pool study results for the trials. Overall, we
noted that there may be little or no effect on stunting (RR 0.94,
95% CI 0.84 to 1.06; two trials; low-certainty evidence; Analysis
1.3).
For wasting, we used the same estimate for the ICC. Analysis
shows there is probably little or no effect of IMCI on wasting (RR
1.04, 95% CI 0.87 to 1.25; two trials;moderate-certainty evidence;
Analysis 1.4).
The Tanzania CBA study gave similar estimates for both parame-
ters.
Quality of care
Arifeen 2009 conducted extensive assessments of quality of care
in facilities, but Schellenberg 2004 measured fewer parameters
(Table 5). Again, these data were collected by direct observation.
Prescribing at health facilities was measured in two studies. Per-
formance in IMCI groups appeared considerably improved in the
Bangladesh trial, and a small improvement in pneumonia correctly
treated was found in Schellenberg 2004, although the base per-
formance level was low. Schellenberg 2004 also measured admin-
istration of antimalarials for fever and found little or no differ-
ence following IMCI implementation (Table 5). As certainty of
the evidence was very low, we do not know whether IMCI has a
consistent effect on prescribing at health facilities.
Three studies measured prescribing by lay health care workers
(Table 6). Investigators examined appropriate treatment under di-
rect observation for three common illnesses: diarrhoea (and oral re-
hydration salts (ORS) use), pneumonia (antibiotic use), and fever
(malaria treatment). As certainty of the evidence was very low, we
do not know whether IMCI had a consistent effect on prescribing
by lay health care workers.
Arifeen2009 examined the appropriateness of referrals (percentage
of children coming to a facility who required referral and were
actually referred) and found little or no difference between IMCI
and non-IMCI clusters (Table 5).
Overall we foundno consistent effect of the interventiononquality
of care provided to beneficiaries.
Coverage of IMCI deliverables
Vaccine coverage
All four studies evaluated immunization coverage among children
in the study populations (Arifeen 2009; Bhandari 2012; Mohan
2011; Schellenberg 2004). Among these, three studied coverage
of the measles vaccine and found probably little or no effect on
measles vaccine coverage (RR 0.92, 95% CI 0.80 to 1.05; two
trials; Tanzania CBA showed a similar result; Analysis 1.5).
Two studies evaluated coverage of the third dose of diphtheria,
pertussis, and tetanus vaccine - one with very low coverage at
follow-up (15.6% in the control group, 21.2% in the IMCI group;
Bhandari 2012) and one with much higher coverage at follow-
up (81.9% IMCI; 93% control; Schellenberg 2004; Analysis 1.6).
The pattern was the same as for measles vaccine, with little or no
evidence of improved coverage with IMCI.
Vitamin A coverage
Two studies reported vitamin A supplementation coverage. In the
Bangladesh trial (Arifeen 2009), coverage was high in both inter-
vention and control areas at baseline and at follow-up. In the Tan-
zania study, vitamin A coverage was low at baseline in both groups
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and was high at follow-up in both groups (Table 7). Analysis of
end values shows that there was probably slightly better coverage
in the control group of the Bangladesh trial (Analysis 1.7).Overall,
there is probably little or no effect of IMCI on vitamin A coverage.
Appropriate care seeking
Care seeking was studied through various parameters in all four
included studies with mixed results: Arifeen 2009 suggested im-
provement in the IMCI group, as did Bhandari 2012 (Table 8;
Analysis 1.9). Schellenberg 2004 did not demonstrate improve-
ment. Mohan 2011 reported on this and suggested better care
seeking for ARI.
Mohan 2011 also reported end values for “change in percentage of
institutional deliveries,” with 9.2% for IMCI and 5.0% for control
and no differences in change detected (RR 4.2%, 95% CI -3.8 to
12.2).
Exclusive breast feeding
Exclusive breast feeding was reported in four studies (Table 9),
which showed mixed results of very low certainty (Analysis 1.8):
One study (Bhandari 2012), which included home visits to en-
courage breast feeding, found a large effect. Other measures re-
lated to breast feeding in this study followed this pattern; in the
intervention group, fewer pre-lacteal feeds were given and breast
feeding was commenced within an hour of birth more commonly,
although these measures were self reported. We noted little differ-
ence in relation to complementary feeding. The other three studies
demonstrated no differences in breast feeding-related parameters.
Newborn care practices
Bhandari 2012 examined several newborn care practices follow-
ing implementation of IMCI. These practices included delayed
bathing, cord care, and appropriate temperature maintenance. In-
vestigators found improvement in all practices, except use of ap-
propriate clothing to maintain newborn temperature while pre-
venting hypothermia.
D I S C U S S I O N
Summary of main results
See Summary of findings for the main comparison.
The integratedmanagement of childhood illness (IMCI) strategies
evaluated in these four studies included training of health care
staff and management strengthening of health systems (all four
studies), as well as home visiting (two studies). Two studies from
India included care packages targeting the neonatal period.
Two studies (Tanzania and Bangladesh) showed that child mortal-
ity may be lower with IMCI, possibly as much as 28-32% lower,
but the confidence interval also included no effect.
One study in India, which implemented the integrated manage-
ment of neonatal and childhood illness (IMNCI) strategy, includ-
ing post-natal home visits, examined infant and neonatal mortal-
ity, suggesting that neonatal and infant mortality may be lower in
the IMNCI group than in the control group.
Three studies (Tanzania, India, Bangladesh) evaluated nutritional
status and noted little or no effect on both stunting and wasting.
Investigators measured quality of care by observing prescribing
for common illnesses in two studies (Tanzania and Bangladesh).
Effects were mixed and ranged from no effect to quite large effects,
so we do not know whether the effect on prescribing quality was
consistent.
For coverage of IMCI deliverables, we examined vaccine coverage,
appropriate care seeking, and exclusive breast feeding. Three stud-
ies (Tanzania, India, Bangladesh) estimated vaccine coverage for
measles, reporting probably little or no effect on measles vaccine
coverage; two of these studies measured the third dose of diphthe-
ria, pertussis, and tetanus vaccine; and two measured vitamin A
coverage, all providing little or no evidence of increased coverage
with IMCI.
Four studies (two from India and one each from Tanzania and
Bangladesh) reported appropriate care seeking, using information
derived from careful questioning of mothers about recent illness.
IMCI areas may show better reported care seeking behavior in
some studies, but not in others.
All four studies recorded maternal responses on exclusive breast
feeding. Results were mixed and were of very low certainty, with
some studies indicating that exclusive breast feeding was higher in
IMCI areas but was not very different in others.
No study reported satisfaction of mothers and service users.
Overall completeness and applicability of
evidence
All included studies involved study populations from low- tomid-
dle-income countries (LMICs) with high infant and child mor-
tality rates; these settings are expected to benefit from IMCI in-
terventions. Three of the four studies evaluated the impact of all
three components of IMCI, and the fourth did not include the
community component. Thus all four studies did include the two
important components, namely, training of workers and strength-
ening of health care systems, but most also included the commu-
nity component. The nature of interventions under each heading
varied among trials (see Table 1).
All included studies were substantive in scope and in length of
follow-up. Control groups in all trials were comparable with inter-
vention groups at baseline and continued to receive routine health
care services as per ongoing programs. Thus any observed effects
in the intervention groups are more likely to be attributable to
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the IMCI strategy than to spontaneous improvements noted over
time. Evidence from these trials is largely applicable to real-life
situations among populations in LMICs.
Three (out of four) studies were conducted in South Asia - two
of these in India; thus the evidence base from African settings is
particularly sparse.
Control groups in all studies received health care, so these studies
evaluated the added value of IMCI or IMNCI. Such added value
is likely to show a modest effect.
Quality of the evidence
Integrated management of childhood illness is a complex inter-
vention, and conducting field trials to assess its impact is undoubt-
edly a challenging task. Therefore, generated evidence is valuable
even if it is graded by the GRADE (Grades of Recommendation,
Assessment, Development and Evaluation Working Group) ap-
proach as having low to moderate certainty (Summary of findings
for the main comparison). Of the four studies included in this re-
view, two were carefully conducted cluster-randomised controlled
trials (Arifeen 2009; Bhandari 2012) with low risk of selection and
recruitment bias, no attrition (loss of clusters), and good baseline
comparability. The two controlled before-after studies (Mohan
2011; Schellenberg 2004) were cluster studies with purposive se-
lection of control and intervention clusters.
All studies included in this systematic review had been funded
or supported by the World Health Organization (WHO) or had
serving employees of WHO as co-authors. As the World Health
Organization is the primary institution responsible for facilitating
global advocacy and implementation of IMCI, we were concerned
about competing interests resulting in over-optimistic interpre-
tation of study results. However, included studies were generally
well conducted and reported.
Potential biases in the review process
Two of the studies were conducted in India, and the lead and se-
nior authors are familiar with these research studies in their own
country. However, the authorship teamwas aware of this potential
bias and ensured that application of inclusion criteria, data extrac-
tion, and interpretation were neutral. During the process of peer
review, we became aware of another trial (Boone 2016) that might
be eligible for inclusion in the review andwill be included whenwe
update this review. It is unlikely that we missed any trials because
such trials are likely to be large, to require extensive funding, and
to be of interest to the World Health Organization, which pro-
motes this strategy. Therefore they are likely to have been picked
up by our exhaustive search strategy, which included contacting
all relevant stakeholders to identify eligible trials.
Agreements and disagreements with other
studies or reviews
To our knowledge, no published systematic review has assessed
the impact of IMCI implementation in population settings (in
children younger than five) on mortality and other outcomes.
A recently published systematic review (Willey 2013) assessed the
effectiveness of interventions to strengthen national health service
delivery; the findings are consistent with our review.
Another systematic review (Nguyen 2013) assessed the impact of
IMCI on the skills of health care workers. This review included
cluster-randomised controlled trials (RCTs), pre/post studies, and
cross-sectional studies and found that IMCI-trained workers per-
formed better in classifying illnesses, prescribing medications, vac-
cinating children, counselling families, and administering oral
therapies. We did not consider these outcomes in our review.
We identified two trials (Amorim 2008; Rowe 2011) that were
excluded because they were non-randomised controlled trials with
single comparison units. Notes of these findings are appended in
the Characteristics of excluded studies table).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Providing accessible comprehensive primary health care services
to children in low- and middle-income countries seems a good ap-
proach to providing health care. This review indicates that IMCI
may have a modest effect on mortality and may well be worth im-
plementing, but policymakers need to be careful about justifying
the considerable investment on the basis that it will result in large
improvements in mortality.
One study measured neonatal and infant mortality and showed
that these may be lower in the IMNCI group than in the control
group. In this study, the strategy included neonatal care, empha-
sizing that these services have the potential to create impact dur-
ing this period when mortality is high. IMCI programmes should
consider including services directed at the neonate (“IMCNI”) as
an integral component of the strategy.
In addition, this strategy, variously implemented in these studies,
did not show consistent effects on quality of care, and the certainty
of evidence was very low because of concerns regarding precision,
consistency, and directness. Therefore we do not know whether
IMCI improves quality of care.
There is a continuing need to assure the components of the IMCI
package are delivered appropriately, that coverage is maintained
and that managerial and support approaches are taken to assure
that appropriate, good quality care is in place.
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Implications for research
Demonstrating an effect on mortality of effective implementation
of routine primary neonatal and child health care services is a large
and expensive undertaking. Many influences on child mortality
occur over time, and studies must be large. Efforts by researchers
to evaluate effects of IMCI help to demonstrate this. In the mean-
time, services and health may be improving over time, as was clear
in Arifeen 2009, which reported dramatic falls in child mortality
over the five years of the study in both intervention and control
arms.
Important further research will involve evaluating strategies that
improve access to, and the quality of, various components of de-
livery of a comprehensive package of primary child health care,
with the IMCI package serving as a base for countries to draw on
and modify as appropriate.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Arifeen 2009
Methods Design: cluster-randomised controlled trial
Unit of randomisation: first-level government health facilities
Participants Children in the health facility catchment area
Bangladesh in one subdistrict not covered by ICCDR,B health care services
Inclusion criteria: 20of 24first-level outpatient facilities in the study area, alongwith their
catchment areas. We excluded four units because substantial portions of their catchment
populations received child health care services from ICDDR,B, not from government
facilities
Meannumbers of children<5 years of age in final census 2006-2007: 2045 (intervention)
; 3045 (control)
Interventions IMCI training
Systems interventions:
community health interventions
Outcomes Mortality
• Mortality in those younger than 5 years of age (7th day to 5 years)
Healthy practices by care giver
• Exclusive breast feeding until 6 months of age
• Complementary feeding
• Care seeking
Quality of care
• Quality of care
• Coverage of IMCI deliverables
Nutritional status
• Wasting
• Stunting
Mortality estimates obtained from population surveys
Notes Objective: to assess effects (and cost-effectiveness) of IMCI on mortality and nutritional
status in children < 5 years of age
Location: Bangladesh, in Matlab upazilla (subdistrict), not covered by child and repro-
ductive health services provided by the ICDDR,B: Centre for Health and Population
Research Total study population was about 350,000
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random allocation of 20 facility/catch-
ment area units between pairs matched
for facility type, geographical distribution,
baseline mortality levels, and catchment
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Arifeen 2009 (Continued)
population size
Allocated by blindly drawing a card with
unit names from each pair and assigning it
to IMCI, then assigning the other to com-
parison
Allocation concealment (selection bias) Low risk “concealed until groups assigned”
Recruitment bias Low risk Units in each pair were randomly selected
(see above)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not mentioned
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not mentioned
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss of clusters
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias High risk Study teams monitored coverage through-
out the study. Early findings for care seek-
ing and referral completion suggest that
coverage was not increasing as rapidly as ex-
pected, leading to changes in the interven-
tion
Baseline imbalance Low risk IMCI and comparison areas were similar at
baseline
Were baseline outcome measurements sim-
ilar
Low risk Yes
Loss of clusters Low risk No loss of clusters reported
Incorrect analysis Low risk Done correctly. Adjusted at catchment/fa-
cility level for clustering, using STATA
Study adequately protected against con-
tamination
Low risk The same children were monitored for
health-related outcomes as at the first visit
for data collection
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Bhandari 2012
Methods Design: cluster-randomised controlled trial
Unit of randomisation: health centre
Participants Children in the catchment area of health centres included
Inclusion criteria: 18 clusters selected in the state of Haryana for the purpose of this
study
Exclusion criteria: none stated
Interventions • Training health care workers to implement integrated management of neonatal
and childhood illness
• Providing systems intervention to improve care delivery
• Improving community health practices
Outcomes Mortality
• Infant mortality
• Neonatal mortality
• Post-neonatal mortality
Standard health practices
• Newborn care practices
• Care seeking behavior
• Immunization coverage
• Wasting and stunting
• Complementary feeding
Notes Objective: to assess India’s adapted IMCI policy (which included home visits for early
newborn care) on newborn and infant mortality, and on newborn care practices
Location: communities with 1.1 million population served by 18 primary health centres
in the district of Faridabad, Haryana, India. The population of each primary health
centre ranged from 10,694 to 72,059. About half the mothers had never been to school,
and two-thirds of births took place at home. Previous studies in the same area showed
that 35% of newborns were of low birth weight and 60% of sick children were taken for
care to medically unqualified private practitioners
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...divided the clusters into three strata con-
taining six clusters each based on neonatal
mortality rate. An independent epidemi-
ologist generated 10 stratified randomisa-
tion schemes to allocate the clusters to
intervention or control groups. The au-
thors examined all 10 potential randomi-
sation schemes, and excluded three be-
cause of chance large differences between
the groups. The authors then randomly se-
lected one of the remaining seven alloca-
tion schemes by a computer generated ran-
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Bhandari 2012 (Continued)
dom number”
Allocation concealment (selection bias) High risk Not mentioned, study author clarification
sought
Recruitment bias Low risk No obvious recruitment bias (see above)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding of community not clear. Surveil-
lance team was not told the intervention
status of the community they were visiting
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not done
Incomplete outcome data (attrition bias)
All outcomes
Low risk Low attrition for neonatal mortality - the
primary outcome. During outcome as-
sessment period (January 2008 to March
2010), study authors registered a total of
77,587 pregnancies, for which outcomes
were not known in 10,239 (13.2%). Of
these, 9954 women were still pregnant
when recruitment of live births in the trial
was stopped; few pregnant women (285)
had left the area or died. Study authors
recorded 5147 (6.6%) miscarriages/abor-
tions, 1499 (1.9%) stillbirths, and 60,702
(78.2%) live births in the study area. Ac-
cording to plan, follow-up ended 6 weeks
after recruitment was completed. Conse-
quently, although almost all recruited live
born infants were followed for the newborn
period (97.8%), only 75.4% were followed
for 6 months and 52.6% until the end of
infancy
Selective reporting (reporting bias) Low risk All primary outcomes reported. Perinatal
mortality (stillbirths and deaths between
birth and day 7 of life) 16 and post-neona-
tal mortality were added to reported out-
comes for completeness
Other bias Low risk None detected
Baseline imbalance Low risk Not apparent
Were baseline outcome measurements sim-
ilar
Low risk Yes, all similar (except on average, IMCI
centres slightly farther from main road)
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Bhandari 2012 (Continued)
Loss of clusters Low risk No loss of clusters reported
Incorrect analysis Low risk Correct for cluster design, using shared
frailty option to account for cluster ran-
domisation (except for neonatal deaths be-
yond first 24 hours of birth and post-
neonatal deaths, for which investigators ad-
justed for cluster design with robust stan-
dard errors, as the shared frailty option
failed)
Study adequately protected against con-
tamination
Low risk Although contiguous, the 18 clusters are
large, and the way health care and worker
responsibilities are organized within a pri-
mary health centre area makes risk of con-
tamination low
Mohan 2011
Methods Design: controlled before-after study.Designwas retrospective based on implementation
Unit of study: district
Participants Children in districts evaluated
Inclusion criteria: The 12 districts (of India) that had initiated IMNCI in 2005 were
selected (subsequently referred to as “early” IMNCI districts). For each “early” IMNCI
district, a control district from the same state, matched on IMR and proportion of
scheduled caste or scheduled tribe, was identified
Exclusion criteria: none stated
Interventions • Training health care workers to implement IMNCI
• Providing systems intervention to improve care delivery
• Improving community health practices
Outcomes Home practices
• Early initiation of breast feeding
• Exclusive breast feeding until 6 months
• ORS-use rates
Service use and coverage
• Percentage of deliveries conducted at a health facility (institutional delivery)
• Full immunization
• Percentage of children with ARI who sought care
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Mohan 2011 (Continued)
Random sequence generation (selection
bias)
High risk Non-randomised trial
Allocation concealment (selection bias) High risk Retrospective data analyses with no men-
tion in text of allocation concealment
Recruitment bias High risk No mention has been made of criteria for
selection of intervention clusters
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Observational study using district-level
household survey: blinding not relevant
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not mentioned but unlikely to have been
done based on study design
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss of clusters, as this is a retrospective
analysis
Selective reporting (reporting bias) Low risk All coverage indicatorsmentioned inmeth-
ods section (Table 1) have been reported
Other bias High risk Data from independent surveys inciden-
tally conducted before and after interven-
tion used for coverage indicators. May not
be exactly before-after data
Baseline imbalance Low risk For each “early” IMNCI district, a control
district from the same state, matched on
IMR and proportion of scheduled caste or
scheduled tribe, was identified
Were baseline outcome measurements sim-
ilar
Unclear risk Baseline outcome measurements not men-
tioned in published text
Loss of clusters Low risk No loss of clusters mentioned in results/
analysis, as the study analysed data on a
retrospective basis
Incorrect analysis Low risk Weighted averages of percentage change in
coverage levels were calculated for interven-
tion and control districts. Net difference
in changes in coverage was then compared
between intervention and control districts
using linear regression with adjustment for
clustering and for sampling weights
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Mohan 2011 (Continued)
Study adequately protected against con-
tamination
Unclear risk Not mentioned
Schellenberg 2004
Methods Design: controlled before-after comparison (also called a “non-randomised controlled
clinical trial”), with monitoring of process measures to improve internal validity and to
determine whether changes are the result of intervention or other factors
Unit of allocation: district
Participants Children in study districts
Inclusion criteria
• The 2 IMCI districts - Morogoro Rural and Rufiji - started to implement IMCI
in 1997-1998, and the 2 comparison districts - Kilombero and Ulanga - started
implementation in 2002
• The 2 comparison districts were chosen for several reasons: They were
geographically contiguous although separated from intervention districts by an
uninhabited game reserve, so population movement between intervention and
comparison areas was negligible; investigators reported continuing demographic
surveillance; had similar or lower mortality rates; and had no immediate plans to
implement IMCI
1932 children < 5 years of age in final survey
Interventions • IMCI training given
• Systems intervention provided
Outcomes Mortality
• Child mortality*
Standard health practices
• Exclusive breast feeding*
• Care seeking for children with danger signs*
Quality of care
• ORS prescription for diarrhoea*
• Antimalarials for fever*
• Vaccine coverage*
Nutritional
• Wasting
• Stunting
• Underweight
*Specified primary outcomes
Notes Objective: to measure effects of IMCI on child health and survival
Location: southern area of Tanzania, poor, rural area with a network of public health
facilities
Risk of bias
Bias Authors’ judgement Support for judgement
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Schellenberg 2004 (Continued)
Random sequence generation (selection
bias)
High risk Not random
Allocation concealment (selection bias) High risk No allocation
Recruitment bias High risk Intervention sites chose to implement
IMCI; control sites had “no immediate
plans”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss of clusters/population
Selective reporting (reporting bias) Low risk Quality outcomes appear comprehensive
Other bias Low risk No other apparent source of bias
Baseline imbalance Unclear risk Baseline data available from 1999, when
IMCI had been partially rolled out in in-
tervention areas
Were baseline outcome measurements sim-
ilar
Unclear risk Baseline data available from 1999, when
IMCI had been partially rolled out in inter-
vention areas. Study authors also mention:
“We could not do a before-IMCI health
facility survey because implementation of
IMCI had already started before this study
began in 1999”
Loss of clusters Low risk No loss of clusters
Incorrect analysis Low risk Adjustments for age (< 1 year and 1 to 4
years) and rainfall (estimated from remote
sensing data) were made with Poisson re-
gression models, and
between-district differenceswere compared
by t-test-based methods of adjusted residu-
als, as appropriate for clustered data, with a
small number of clusters in only 4 districts.
P values from this approach are likely to be
conservative
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Schellenberg 2004 (Continued)
Study adequately protected against con-
tamination
Low risk The 2 comparison districts were chosen
for several reasons: They were geographi-
cally contiguous although separated from
intervention districts by an uninhabited
game reserve, so population movement be-
tween intervention and comparison areas
was negligible
ARI: acute respiratory infection
ICDDR,B: International Center for Diarrheal Disease Research, Bangladesh
IMCI: integrated management of childhood illness
IMNCI: integrated management of neonatal and childhood illness
ORS: oral rehydration salts
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adam 2009 Involves secondary analysis from an included trial; outcome not of interest
Ali 2005 CBA study with 1 intervention and 1 control cluster (district)
Intervention comprised a non-specific community-based public health intervention derived from com-
munity component of IMCI
Almagambetova 2000 Short report summarizing conclusions from a strategy implementation conference on IMCI, not primary
research
Amorim 2008 • Retrospective analysis in which allocation was done by level of performance of clusters in
implementation of IMCI, which is likely to confound results as well
• Baseline data (before implementation of IMCI) not available
• ITT analysis not done
[The analysis, mentioned in the Discussion, showed 72% of 175 children were correctly managed in
IMCI areas; 56% of 183 were correctly managed in non-IMCI facilities (P value = 0.02). IMCI was
associated with 30% higher quality of case management]
Atakuoma Dzayisse 2006 Non-randomised controlled cross-sectional trial with 1 intervention and 1 control cluster
Bradley 2005 Intervention did not involve IMCI
Camara 2008 No control group
Chopra 2005 No control group
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(Continued)
Chowdhury 2008 Observational study, no control group (subset of Arifeen study that studies the outcome of treatment
guidelines for pneumonia in IMCI area)
Core Group 2009 Study has no control group
Studies the impact of community IMCI component only
Ebuehi 2009 Studies the impact of community IMCI component only (3 components vs 2 components of IMCI).
Only 2 study clusters: 1 in the intervention arm and the other in the control arm
Ebuehi 2010 CBA study with only 1 intervention and 1 control cluster; intervention involved assessed only the C-
IMNCI component of IMCI. Intervention zone had all 3 components vs first 2 components of IMCI
in control area
Edward 2007 Pre- and post-intervention study with no control group
Ertem 2006 Intervention involved care for development, which is a component of IMCI, and not generic IMCI;
outcome studied was mental development, which was not of interest
Esaghi 2012 Non-randomised controlled trial with 1 study group and 1 control cluster. Excluded because fewer than
2 clusters in study and control groups
Gebresellasie 2011 Intervention consisted of health education component only for IMCI. Essential component of health
worker training was missing. Only 1 control and 1 intervention component in a non-randomised con-
trolled trial
Ghimire 2010 Intervention involved health education component only for IMCI. Essential component of health worker
training was missing
Gilroy 2004 Outcome not of interest; pertains to counselling tasks by IMCI provider
Gouws 2004 Study is a secondary analysis of data collected from WHO MCE studies
Hamad 2011 Intervention consisted only of health education component of IMCI. Essential component of health
worker training was missing
Harkins 2008 Assesses effects of community IMCI only; no control group
Huicho 2005 No control group
Huicho 2008 Observational study, no control group
Outcomes not of interest
Igarashi 2010 Intervention consisted of assessment of GMP+, which is a community-based program based on PHC
and IMCI. IMCI services provided in both control and intervention areas
Jin 2007 Intervention involved care for development module, which is part of IMCI, and not the WHO generic
IMCI
Outcome studied was mental development, which was not of interest
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(Continued)
Kelley 2001 Intervention consisted of performance feedback on compliance with IMCI protocol by health care
workers
Kumar 2009 Study compared 5 days vs 8 days of training of health care workers on the basis of performance; no
control group included
Lulseged 2002 Narrative review of Ethiopia’s experience with IMCI; no data presented
Mahalli 2011 Retrospective cohort study with 1 study group and 1 control cluster
Excluded because fewer than 2 clusters were included in study and control groups, and outcome was
drug prescribing practices, which was not of interest
Mohan 2004 Doctors in both intervention and control clusters received training of different duration; no control
group
Moti 2008 • Comparison of 1 implementation cluster vs 1 control cluster
• Control cluster also had partial rollout of IMCI program
Naimoli 2006 Study is a cross-sectional survey conducted in 2 control and 2 intervention clusters 6 to 12 months after
implementation of IMCI, with no baseline data; does not qualify as a CBA trial
Oluwole 2000 Editorial reviewing the impact of IMCI, not an original research study
Osterholt 2009 Study compared provision of IMCI with “usual” supports vs IMCI training with special supports (job
aids, non-financial incentives, and supervision of workers and Supervisors). Thus health care workers
received IMCI training in both groups with no control group included
Pariyo 2005 No study and intervention population. Analysis compares the performance of health care workers by
IMCI training
No data on performance of health care workers before they were trained for IMCI
Pelto 2004 Intervention involved an IMCI derived nutrition counselling protocol, not the entire generic IMCI
training
Prado 2006 Intervention involved Family Health Program, in whose context IMCI is being implemented,
but involved 1 control and intervention cluster only. Outcome of maternal knowledge, which was not
of interest
Rakha 2013 No control group (retrospective analysis of mortality data before and after implementation of IMCI)
Rowe 2011 Non-randomised controlled trial with 1 intervention and 1 control cluster. Excluded because fewer than
2 clusters were found in study and control groups
[the analysis is mentioned in the Discussion. In intervention area, mortality decreased (risk ratio (RR)
0.870, 95% CI 0.841 to 0.900); in comparison area, mortality unchanged (RR 1.013, 95% CI 0.979 to
1.049). Intervention-area trend was 14.1% lower than comparison-area trend (95% CI 9.8% to 18.2%)
Santos 2001 Intervention consisted of IMCI-derived nutrition counselling protocol, not the entire generic IMCI
training
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(Continued)
Senn 2011 No control group
Talsania 2011 Intervention consisted of health education component only for IMCI. Essential component of health
care worker training was missing
Thompson 2009 Study has no control group. Studies the impact of community IMCI component only
Uzochukwu 2008 Assesses effects of short-term training of IMCI on health care worker performance with no control group
Wammanda 2003 No control group; intervention does not involve IMCI training; outcome (cost of drugs prescribed) not
of interest
Zaman 2008 Study had just 1 module of IMCI, namely, nutrition counselling, not generic IMCI as the intervention
Zhang 2007 Pre- and post-intervention field survey with no control group
Zurovac 2006 Qualitative review of studies on treatment of febrile illness in sub-Saharan Africa - obviously irrelevant
CBA: controlled before-after study
CI: confidence interval
C-IMNCI: community integrated management of neonatal and childhood illness
IMCI: integrated management of childhood illness
ITT: intention-to-treat
MCE: Multi-Country Evaluation of IMCI Effectiveness, Cost and Impact
PHC: primary health care
RR: risk ratio
WHO: World Health Organization
Characteristics of studies awaiting assessment [ordered by study ID]
Boone 2016
Methods Design: cluster RCT
Unit of allocation: villages or groups of villages
Participants Women between 15 and 49 years of age; those who were primary care givers of children younger than 5 years of age
Children younger than 5 years of age
Interventions • Providing IMCI training of community health care workers
• Improving community health practices
Outcomes • Under 5 mortality
• Neonatal and infant mortality
• Child morbidity
• Maternal mortality
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Boone 2016 (Continued)
• Treatment practices for sick children
Notes
· Characteristics of studies, Characteristics of studies awaiting classification: Insert these footnotes at end of section:
IMCI: integrated management of childhood illness
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. IMCI versus standard services
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality 3 Rate Ratio (Fixed, 95% CI) Totals not selected
1.1 Neonatal mortality (RCT) 1 Rate Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Infant mortality (RCT) 1 Rate Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Child mortality (RCT) 1 Rate Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Child mortality (CBA) 1 Rate Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Mortality (infant and child
combined)
2 Rate Ratio (Fixed, 95% CI) 0.85 [0.78, 0.93]
2.1 Child mortality 1 Rate Ratio (Fixed, 95% CI) 0.87 [0.68, 1.10]
2.2 Infant mortality 1 Rate Ratio (Fixed, 95% CI) 0.85 [0.77, 0.94]
3 Stunting 3 Risk Ratio (Random, 95% CI) Subtotals only
3.1 Cluster RCTs 2 Risk Ratio (Random, 95% CI) 0.94 [0.84, 1.06]
3.2 CBA studies 1 Risk Ratio (Random, 95% CI) 1.06 [0.92, 1.23]
4 Wasting 3 Risk Ratio (Fixed, 95% CI) Subtotals only
4.1 Cluster RCTs 2 Risk Ratio (Fixed, 95% CI) 1.04 [0.87, 1.25]
4.2 CBA studies 1 Risk Ratio (Fixed, 95% CI) 1.20 [0.54, 2.68]
5 Measles vaccine coverage 3 Risk Ratio (Fixed, 95% CI) Subtotals only
5.1 Cluster RCTs 2 Risk Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
5.2 CBA studies 1 Risk Ratio (Fixed, 95% CI) 0.95 [0.89, 1.01]
6 DPT vaccine coverage 2 Risk Ratio (Fixed, 95% CI) Subtotals only
6.1 Cluster RCTs 1 Risk Ratio (Fixed, 95% CI) 0.95 [0.68, 1.33]
6.2 CBA studies 1 Risk Ratio (Fixed, 95% CI) 0.86 [0.80, 0.92]
7 Vitamin A vaccine coverage 2 Risk Ratio (Fixed, 95% CI) Subtotals only
7.1 Cluster RCTs 1 Risk Ratio (Fixed, 95% CI) 0.93 [0.88, 0.98]
7.2 CBA studies 1 Risk Ratio (Fixed, 95% CI) 1.00 [0.90, 1.12]
8 IMCI deliverable - exclusive
breast feeding
3 Risk Ratio (Fixed, 95% CI) Totals not selected
8.1 Cluster RCTs 2 Risk Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 CBA studies 1 Risk Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Appropriate care seeking 3 Risk Ratio (Fixed, 95% CI) Totals not selected
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Analysis 1.1. Comparison 1 IMCI versus standard services, Outcome 1 Mortality.
Review: Integrated management of childhood illness (IMCI) strategy for children under five
Comparison: 1 IMCI versus standard services
Outcome: 1 Mortality
Study or subgroup log [Rate Ratio] Rate Ratio Rate Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Neonatal mortality (RCT)
Bhandari 2012 -0.0943 (0.0632) 0.91 [ 0.80, 1.03 ]
2 Infant mortality (RCT)
Bhandari 2012 -0.1625 (0.0504) 0.85 [ 0.77, 0.94 ]
3 Child mortality (RCT)
Arifeen 2009 -0.1438704 (0.1229592) 0.87 [ 0.68, 1.10 ]
4 Child mortality (CBA)
Schellenberg 2004 -0.1392621 (0.0943878) 0.87 [ 0.72, 1.05 ]
0.01 0.1 1 10 100
Favours IMCI Favours control
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Analysis 1.2. Comparison 1 IMCI versus standard services, Outcome 2 Mortality (infant and child
combined).
Review: Integrated management of childhood illness (IMCI) strategy for children under five
Comparison: 1 IMCI versus standard services
Outcome: 2 Mortality (infant and child combined)
Study or subgroup log [Rate Ratio] Rate Ratio Weight Rate Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Child mortality
Arifeen 2009 -0.1438704 (0.1229592) 14.4 % 0.87 [ 0.68, 1.10 ]
Subtotal (95% CI) 14.4 % 0.87 [ 0.68, 1.10 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.17 (P = 0.24)
2 Infant mortality
Bhandari 2012 -0.1625 (0.0504) 85.6 % 0.85 [ 0.77, 0.94 ]
Subtotal (95% CI) 85.6 % 0.85 [ 0.77, 0.94 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.22 (P = 0.0013)
Total (95% CI) 100.0 % 0.85 [ 0.78, 0.93 ]
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 3.43 (P = 0.00061)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.89), I2 =0.0%
0.01 0.1 1 10 100
Favours IMCI Favours control
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Analysis 1.3. Comparison 1 IMCI versus standard services, Outcome 3 Stunting.
Review: Integrated management of childhood illness (IMCI) strategy for children under five
Comparison: 1 IMCI versus standard services
Outcome: 3 Stunting
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
1 Cluster RCTs
Arifeen 2009 (1) -0.1272 (0.0565) 40.9 % 0.88 [ 0.79, 0.98 ]
Bhandari 2012 -0.0101 (0.0264) 59.1 % 0.99 [ 0.94, 1.04 ]
Subtotal (95% CI) 100.0 % 0.94 [ 0.84, 1.06 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 3.53, df = 1 (P = 0.06); I2 =72%
Test for overall effect: Z = 1.01 (P = 0.31)
2 CBA studies
Schellenberg 2004 0.0611 (0.0738) 100.0 % 1.06 [ 0.92, 1.23 ]
Subtotal (95% CI) 100.0 % 1.06 [ 0.92, 1.23 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Chi2 = 1.62, df = 1 (P = 0.20), I2 =38%
0.5 0.7 1 1.5 2
Favours IMCI Favours control
(1) Arifeen adjusted for clustering using an ICC of 0.01. Bhandari is adjusted
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Analysis 1.4. Comparison 1 IMCI versus standard services, Outcome 4 Wasting.
Review: Integrated management of childhood illness (IMCI) strategy for children under five
Comparison: 1 IMCI versus standard services
Outcome: 4 Wasting
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Cluster RCTs
Arifeen 2009 (1) -0.1215 (0.1772) 25.9 % 0.89 [ 0.63, 1.25 ]
Bhandari 2012 0.0998 (0.1047) 74.1 % 1.10 [ 0.90, 1.36 ]
Subtotal (95% CI) 100.0 % 1.04 [ 0.87, 1.25 ]
Heterogeneity: Chi2 = 1.16, df = 1 (P = 0.28); I2 =14%
Test for overall effect: Z = 0.47 (P = 0.64)
2 CBA studies
Schellenberg 2004 0.1862 (0.4075) 100.0 % 1.20 [ 0.54, 2.68 ]
Subtotal (95% CI) 100.0 % 1.20 [ 0.54, 2.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.46 (P = 0.65)
Test for subgroup differences: Chi2 = 0.12, df = 1 (P = 0.73), I2 =0.0%
0.5 0.7 1 1.5 2
Favours IMCI Favours Control
(1) Arifeen adjusted for clustering using ICC 0.01. Bhandari is adjusted
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Analysis 1.5. Comparison 1 IMCI versus standard services, Outcome 5 Measles vaccine coverage.
Review: Integrated management of childhood illness (IMCI) strategy for children under five
Comparison: 1 IMCI versus standard services
Outcome: 5 Measles vaccine coverage
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Cluster RCTs
Arifeen 2009 (1) -0.086 (0.0744) 85.0 % 0.92 [ 0.79, 1.06 ]
Bhandari 2012 -0.0834 (0.1772) 15.0 % 0.92 [ 0.65, 1.30 ]
Subtotal (95% CI) 100.0 % 0.92 [ 0.80, 1.05 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 1.25 (P = 0.21)
2 CBA studies
Schellenberg 2004 -0.0523 (0.0326) 100.0 % 0.95 [ 0.89, 1.01 ]
Subtotal (95% CI) 100.0 % 0.95 [ 0.89, 1.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.60 (P = 0.11)
Test for subgroup differences: Chi2 = 0.19, df = 1 (P = 0.66), I2 =0.0%
0.5 0.7 1 1.5 2
Favours control Favours IMCI
(1) Adjusted for clustering using an estimated ICC of 0.01
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Analysis 1.6. Comparison 1 IMCI versus standard services, Outcome 6 DPT vaccine coverage.
Review: Integrated management of childhood illness (IMCI) strategy for children under five
Comparison: 1 IMCI versus standard services
Outcome: 6 DPT vaccine coverage
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Cluster RCTs
Bhandari 2012 -0.0513 (0.1706) 100.0 % 0.95 [ 0.68, 1.33 ]
Subtotal (95% CI) 100.0 % 0.95 [ 0.68, 1.33 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
2 CBA studies
Schellenberg 2004 -0.1503 (0.0369) 100.0 % 0.86 [ 0.80, 0.92 ]
Subtotal (95% CI) 100.0 % 0.86 [ 0.80, 0.92 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.07 (P = 0.000046)
Test for subgroup differences: Chi2 = 0.32, df = 1 (P = 0.57), I2 =0.0%
0.5 0.7 1 1.5 2
Favours control Favours IMCI
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Analysis 1.7. Comparison 1 IMCI versus standard services, Outcome 7 Vitamin A vaccine coverage.
Review: Integrated management of childhood illness (IMCI) strategy for children under five
Comparison: 1 IMCI versus standard services
Outcome: 7 Vitamin A vaccine coverage
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Cluster RCTs
Arifeen 2009 (1) -0.0738 (0.0292) 100.0 % 0.93 [ 0.88, 0.98 ]
Subtotal (95% CI) 100.0 % 0.93 [ 0.88, 0.98 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.53 (P = 0.011)
2 CBA studies
Schellenberg 2004 0.0032 (0.0559) 100.0 % 1.00 [ 0.90, 1.12 ]
Subtotal (95% CI) 100.0 % 1.00 [ 0.90, 1.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
Test for subgroup differences: Chi2 = 1.49, df = 1 (P = 0.22), I2 =33%
0.5 0.7 1 1.5 2
Favours control Favours IMCI
(1) We adjusted for clustering using ICC 0.01
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Analysis 1.8. Comparison 1 IMCI versus standard services, Outcome 8 IMCI deliverable - exclusive breast
feeding.
Review: Integrated management of childhood illness (IMCI) strategy for children under five
Comparison: 1 IMCI versus standard services
Outcome: 8 IMCI deliverable - exclusive breast feeding
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Cluster RCTs
Arifeen 2009 (1) 0.4759 (0.2386) 1.61 [ 1.01, 2.57 ]
Bhandari 2012 1.8437 (0.0908) 6.32 [ 5.29, 7.55 ]
2 CBA studies
Schellenberg 2004 -0.4735 (0.4158) 0.62 [ 0.28, 1.41 ]
0.05 0.2 1 5 20
Favours control Favours IMCI
(1) Arifeen adjusted for clustering using ICC 0.01. Bhandari already adjusted
Analysis 1.9. Comparison 1 IMCI versus standard services, Outcome 9 Appropriate care seeking.
Review: Integrated management of childhood illness (IMCI) strategy for children under five
Comparison: 1 IMCI versus standard services
Outcome: 9 Appropriate care seeking
Study or subgroup log [Risk Ratio] Risk Ratio Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
Arifeen 2009 1.6015 (0.2636) 4.96 [ 2.96, 8.32 ]
Bhandari 2012 0.5653 (0.1241) 1.76 [ 1.38, 2.24 ]
Schellenberg 2004 0.168 (0.0891) 1.18 [ 0.99, 1.41 ]
0.01 0.1 1 10 100
Favours control Favours IMCI
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A D D I T I O N A L T A B L E S
Table 1. IMCI components
Schellenberg
2004
Arifeen 2009 Mohan 2011 Bhandari 2012
Human re-
sources policies
for health care
professionals
IMCI training Basic health care
worker
Y Y Y Y
Senior/other Y Y
Doctors Y
TBA Y
Refresher
Private sector Y
Staff recruitment Filling vacancies Y
New
cadre of commu-
nity health care
worker (CHW)
Y
Conditions of
service
Cash incentives Y
Management Home visits Y Y Y
Supervision and
monitoring
Y Y Y
Health system
strengthening
Tools and manu-
als including
guidelines
Supply educa-
tion materials
Y Y
Additional
equipment and
drugs
Drug supply Ya Y Y Y
Supply minor
equipment
Y
Strategies for
community en-
gagement
Training Unqualified vil-
lage doctors
Y Y
Social develop-
ment
Establishing
mother/women
group meetings
Y Y
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Table 1. IMCI components (Continued)
Support of com-
munity leaders/
volunteers
Y
Community the-
atre
Y
IMCI: integrated management of childhood illness; TBA: traditional birth attendant
aAssumed, as the study is an assessment of first 2 components of World Health Organization (WHO) generic integrated management
of childhood illness (IMCI)
Table 2. Details of inputs described narratively
Study Input
Schellenberg 2004 Incorporated 2 components of integrated management of childhood illness (IMCI), namely, training of health
care workers and health system strengthening. All health care workers at the primary level received 11 days of
training. IMCI nutrition education and counselling cards for educating mothers were prepared after operational
research and subsequently translated into Swahili language to improve community practices. Health systems
were strengthened using IMCI processes and by providing financial resources of approximately $0.92 per capita
to implementing districts
Arifeen 2009 Incorporated all 3 components of IMCI. Health care workers were trained using the 11-day course, followed by
a 3-day course on breast feeding counselling. Health systems strengthening consisted of making additional drugs
available in the intervention area, and setting up a facility-level drug tracking and reporting system. Job aids
such as weighing scales, timer to count respiratory rate, thermometers, chart booklets, and locally adapted cards
as aids for counselling mothers were provided to all intervention clusters. To improve community practices,
special emphasis was given to messages related to pneumonia and malnutrition and to 3 practice areas, namely,
care seeking for sick children, home management of illness, and responsive feeding
Mohan 2011 Retrospectively collected data about IMCI implementation from 12 districts that started implementation in
2005. Details of the intervention have not been described specifically for these 12 districts but are available
for the entire country as part of a standard guideline. Training consisted of the 8-day course for community-
based workers and auxiliary nurse midwives and an additional 2 days for supervisors. Workers are supposed
to receive basic drugs and supplies as per guidelines of the Reproductive and Child Health II and Integrated
ChildDevelopment Scheme (ICDS) programs. Community health practices include home visits to all newborns
during which health care workers ensure exclusive breast feeding, provide counsel on temperature maintenance,
explain danger signs, assess newborns (and other sick children) and refer them to an appropriate health facility,
if required
Bhandari 2012 Health care workers were trained with the 8-day IMNCI Basic Health Worker Course, and specialists received
the 11-day IMNCI Course for Physicians. Health systems interventions included (1) strengthened supervision
of community health care workers and nurses and filling of vacant supervisor positions; (2) task-based incentives
to include IMNCI activities; and (3) establishment of drug depots in villages to ensure regular supply of drugs.
Community health care workers made scheduled post-natal home visits, promoted breast feeding, delayed
bathing, provided cord care, and responded to care seeking for illness. They also ran women’s health group
meetings to increase awareness of healthy newborn care practices
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Table 3. Results: mortality
Outcome Trial ID Study
design
Pre-intervention mortal-
ity rate
Post-intervention mortal-
ity rate
Cluster-ad-
justed rela-
tive effect
(95% CI)
Coverage
indicators
analysis
summary
IMCI Control IMCI Control
Neonatal
mortality
Bhandari
2012a
Cluster
RCT
32.6/1000
live births
(n NA)
32.4/1000
live births
(n NA)
41.9/1000
live births
(1244/29,
667)
43/1000 live
births
(1326/30,
813)
Hazard ra-
tio 0.91b,c
(0.80 to 1.
03)
Adjusted for
confounders
Infant mor-
tality
Bhandari
2012
Cluster
RCT
44.9/1000
live births
(n NA)
43.9/1000
live births
(n NA)
65 per 1000
live births
(1925/29,
667)
69 per 1000
live births
(2136/30,
813)
Hazard ra-
tio 0.85b
(0.77 to 0.
94)
Adjusted for
confounders
Child mor-
tality
Arifeen
2009d
Cluster
RCT
43.0
per 1000 live
births
(144/3348)
44.8
per 1000 live
births
(179/3996)
27.0
per 1000 live
births
(157/5815)
31.2
per 1000 live
births
(221/7083)
Risk ratio
0.87
(0.66 to 1.
14)
No effect af-
ter exclusion
of injuriese
Schellen-
berg
2004f
CBA 27.
2 per 1000
child-years
(639/23,
515)
27.
0 per 1000
child-years
(242/8977)
24.
4 per 1000
child-years
(1220/49,
964)
28.2 per
1000 years
(619/21,
965)
Risk ratio
0.87
(0.72 to 1.
05)
No effect af-
ter
adjustment
CBA: controlled before-after study; IMCI: integrated management of childhood illness; RCT: randomised controlled trial
aBhandari 2012: Fieldworkers not involved with IMNCI implementation visited households monthly to identify new pregnancies.
Infants were visited at 1, 3, 6, 9, and 12 months to determine survival
bBhandari 2012: Hazard ratio was calculated after adjustment for cluster design and potential confounders between groups (markers
of poverty, literacy, access to services)
cBhandari 2012: Although the overall effect was not statistically significant, a subgroup analysis found that a statistically significant
reduction in neonatal mortality was significantly lower in the subgroup born at home (adjusted HR 0.80, 95% CI 0.68 to 0.93)
dArifeen conducted a household census in 2000 and 2007 where the complete birth history of all ever married women between the
age of 15 and 49 years was used to estimate yearly and 2 year mortality rates. The data pertains to mortality between day 7 and 5 years
of life.
eAfter exclusion of deaths due to malformation and injury (causes not related to IMCI), no effect of IMCI was noted on mortality
(data not available)
fThis is the value adjusted for baseline differences in mortality. Unadjusted value is 4.2/1000 fewer deaths (95% CI -4.1 to 12.4).
Mortality was slightly higher in the control group at baseline. Schellenberg study (Schellenberg 2004)
Also estimated mortality difference after “ignoring the between district variation” as 13% lower mortality (95% CI 5% to 21% lower)
(P value = 0.004); risk ratio 0.87 (95% CI 0.79 to 0.95)
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Table 4. Results: nutritional parameters
Parameter Study Study design Pre-intervention Post-intervention
IMCI
% (n/N)
Control
% (n/N)
IMCI
% (n/N)
Control
% (n/N)
Wasting Arifeen 2009a Cluster RCT 21.5%
(74/346)
21.6%
(95/439)
12.6%
(89/706)
14.3%
(101/709)
Schellenberg
2004b
CBA 12.57%
(21/167)
10.5%
(21/200)
6.8%
(13/191)
5.6%
(10/177)
Bhandari 2012 Cluster RCT 16.6%
(243/1461)
14.3%
(202/1412)
Stunting Arifeen 2009c Cluster RCT 63.1%
(334/530)
62.5%
(432/692)
50.4%
(599/1189)
57.1%
(674/1180)
Schellenberg
2004c,d
CBA 59.7%
(297/497)
51.1%
(247/483)
42.6%
(249/585)
40.0%
(191/477)
Bhandari 2012 Cluster RCT 49.6%
(725/1461)
48.2%
(680/1412)
Low weight for
age
Schellenberg
2004e
CBA 30.6%
(290/947)
26.3%
(238/905)
23.4%
(234/1001)
19.5%
(161/825)
HAZ score
Mean (SD)
Arifeen 2009 Cluster RCT -2.35 (0.20) -2.39 (0.33) -2.01 (0.14) -2.17 (0.20)
WHZ score
Mean (SD)
Arifeen 2009 Cluster RCT -1.18 (0.20) -1.23 (0.19) -0.77 (0.25) -0.84 (0.14)
CBA: controlled before-after; HAZ: height for age z-score; IMCI: integrated management of childhood illness; RCT: randomised
controlled trial;WHZ: weight for age z-score
aWHZ ≤ 2 in children 0 to 23 months of age. Data from baseline and end surveys
bWHZ ≤ 2 in children 12 to 23 months of age. Data from baseline and end surveys
cHAZ ≤ 2 in children 24 to 59 months of age. Data from baseline and end surveys
dWhen expressed as mean haz scores, differential change between IMCI and comparison districts reached statistical significance (data
not available/depicted)
eWAZ ≤ 2. Data from baseline and end surveys
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Table 5. Results: quality (facility level)
Outcome Study Pre-intervention Post-intervention
IMCI
% (n/N)
Control
% (n/N)
IMCI
% (n/N)
Control
% (n/N)
Index of integrated
assessment (0 to
100)
Arifeen 2009a - - 85.0%
(150/176)
11.0%
(15/132)
Correct
management of all
illness
Arifeen 2009a - - 64.6%
(111/172)
10.2%
(13/131)
Children with de-
hydration
correctly treated
Arifeen 2009a - - 28.7%
(1/4)
0.0%
(0/2)
Schellenberg 2004b - - 20.0%
(1/5)
0.0%
(0/3)
Child with pneu-
monia correctly
treated
Arifeen 2009a - - 80.8%
(46/ 57)
3.4%
(1/ 31)
Schellenberg 2004b - - 19.5%
(45/231)
10.1%
(19/188)
Child
with anaemia cor-
rectly treated
Arifeen 2009a - - 0.0%
(3)
0.0%
(5)
Child needing re-
ferral was referred
Arifeen 2009a - - 35.7%
(2/6)
25.0 %
(1/4)
Children with
fever treated with
antimalarials
Schellenberg 2004b 39.4%
(147/373)
44.5%
(153/344)
27.4%
(108/394)
34.2%
(80/234)
IMCI: integrated management of childhood illness
aData from health facility surveys done in 2003 and 2005 and estimates weighted by total number of sick children seen in facilities on
survey days.
Baseline data collected in 2003, 1 year after initiation of facility-based IMCI. Indicators based on IMCI health facility survey guidelines
bData from household surveys conducted in 1999 and 2002
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Table 6. Results: quality (prescribing by lay health care workers)
Outcome Study Study design Pre-Intervention Post-intervention
IMCI
% (n/N)
Control
% (n/N)
IMCI
% (n/N)
Control
% (n/N)
Chil-
dren with di-
arrhoea treated
with ORS
Arifeen 2009 Cluster RCT - - 48%
(60/125)
30%
(32/108)
Schellenberg
2004a
CBA 24.7%
(21/85)
10.4%
(10/96)
25.3%
(23/91)
19.0%
(15/79)
Change in % of
chil-
dren with di-
arrhoea treated
with ORS
Mohan 2011b CBA - - 1.6% 0.7%
Children with
suspected pneu-
monia treated
with antibiotics
Arifeen 2009 Cluster RCT - - 52%
(156/300)
48%
(167/348)
CBA: controlled before-after study; IMCI: integrated management of childhood illness;ORS: oral rehydration salts; RCT: randomised
controlled trial
aProportion of children ill in the last 2 weeks of the survey at baseline and at end of study period who were taken to an appropriate
health care provider
bData collected from 2 rounds of district-level health surveys in districts that implemented IMCI in 2005 and in control districts
matched for IMR and proportion of scheduled castes and scheduled tribes. Weighted average of percentage change in coverage levels
calculated for the 2 groups
Table 7. Results: coverage (vaccines)
Parameter Study Study design Pre-intervention Post-intervention
IMCI
% (n/N)
Control
% (n/N)
IMCI
% (n/N)
Control
% (n/N)
Measles vaccine
coverage
Arifeen 2009a,b Cluster RCT 36.9%
(124/335)
32.2%
(131/406)
52.7%
(219/416)
57.4%
(239/417)
Bhandari 2012 Cluster RCT 11.1%
(226/2045)
16.8%
(339/2017)
Schellenberg
2004c
CBA 88.3%
(159/180)
89.4%
(194/217)
88.2%
(180/204)
93.0%
(172/185)
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Table 7. Results: coverage (vaccines) (Continued)
Change in cov-
erage of all vac-
cines
Mohan 2011d,e CBA - - 3.8% 11.1%
DPT3 vaccine
coverage
Bhandari 2012 Cluster RCT 15.6%
(318/2045)
21.2%
(427/2017)
Schellenberg
2004c
CBA 87.2%
(157/180)
85.3%
(185/217)
81.9%
(167/204)
95.1%
(176/185)
Vitamin
A supplementa-
tion coverage
Arifeen 2009a Cluster RCT 82.1%
(272/331)
74.4%
(301/405)
85.3%
(355/416)
91.7%
(381/415)
Schellenberg
2004c
CBA 12.9%
(25/194)
13.5%
(28/208)
77%
(154/200)
76.8%
(142/185)
CBA: controlled before-after study; DPT: Diphtheria-Pertussis-Tetanus; IMCI: integrated management of childhood illness; RCT:
randomised controlled trial
aData available from 6 monthly household surveys at baseline and at end
bData collected from vaccination cards
cData collected through information or registration during household surveys
dData collected from 2 rounds of district-level health surveys in districts that implemented IMCI in 2005 and in control districts
matched for IMR and proportion of scheduled castes and scheduled tribes. Weighted average of percentage change in coverage levels
calculated for the 2 groups
eChange in proportion of children fully immunized
Table 8. Results: coverage (care seeking behavior)
Outcome Study Study design Pre-intervention Post-intervention
IMCI
% (n/N)
Control
% (n/N)
IMCI
% (n/N)
Control
% (n/N)
Change (%)
children
with ARI seek-
ing care
Mohan 2011a CBA NA NA +6.7% -11.1%
Appropriate
care seeking
Bhandari 2012b Cluster RCT NA NA 46.9%
(474/1010)
29.5%
(374/1269)
Arifeen 2009c Cluster RCT 6%
(18/302)
4%
14/360)
24%
(111/462)
5%
(24/483)
Schellenberg
2004d
CBA 41.2%
211/512)
42.2%
(212/502)
38.2%
(203/531)
32.3%
(138/427)
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Table 8. Results: coverage (care seeking behavior) (Continued)
Care seeking for
children with
danger signs
Schellenberg
2004d
CBA 53.1%
(86/162)
68%
(100/147)
54.9%
(78/142)
43.4%
(49/113)
ARI: acute respiratory infection; CBA: controlled before-after study; IMCI: integrated management of childhood illness; IMR: infant
mortality rate; RCT: randomised controlled trial
aData collected from 2 rounds of district-level health surveys in districts that implemented IMCI in 2005 and in control districts
matched for IMR and proportion of scheduled castes and scheduled tribes. Weighted average of percentage change in coverage levels
calculated for the 2 groups
bProportion of neonates with danger signs who were taken to an appropriate health care provider (physician in government or private
health facility or community health care worker)
cProportion of children ill in the last 2 weeks of the survey at baseline and at end of study period who were taken to an appropriate
health care provider
dData from household surveys conducted in 1999 and 2002
Table 9. Results: coverage (breast feeding and other child rearing practices)
Practice Study Study design Pre-intervention Post-intervention
IMCI
% (n/N)
Control
% (n/N)
IMCI
% (n/N)
Control
% (n/N)
Exclusive breast
feeding
Bhandari 2012
a,b
Cluster RCT - - 77.6%
(4811/6204)
37.3%
(2300/6163)
Arifeen 2009c Cluster RCT 56.3%
(825/1466)
56.2%
(1021/1817)
75.5%
(1024/1356)
65.3%
(1149/1759)
Schellenberg
2004d
CBA 20.7%
(23/111)
26.1%
(18/69)
22.7%
(15/66)
32.1%
(17/53)
Mohan 2011e CBA - - 30.0% 24.3%
Complemen-
tary feeding
Arifeen 2009f Cluster RCT 60.4%
(734/1216)
52.8%
(873/1653)
67.6%
(792/1172)
57.2%
(783/1369)
Schellenberg
2004f
CBA 89.9%
(71/79)
95.9%
(70/73)
98.8%
(80/81)
98.7%
(74/75)
Bhandari 2012g Cluster RCT 33.6%
(687/2045)
37.6%
(759/2017)
Pre-lacteal feeds
not given
Bhandari 2012a Cluster RCT - - 80.2%
(4977/6204)
32.6%
(2006/6163)
Breast feeding
initiated
within 1 hour of
Bhandari 2012a Cluster RCT - - 40.7%
(2527/6204)
11.2%
(689/6163)
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Table 9. Results: coverage (breast feeding and other child rearing practices) (Continued)
birth
Mohan 2011e CBA - - 18.1% 13.6%
Newborn care
practices
Delayed
bathing
Bhandari 2012a Cluster RCT - - 84.5%
(5243/6204)
46.2%
(2848/6163)
Cord care Bhandari 2012
a,h
Cluster RCT 84.1%
(5219/6204)
39.5%
(2436/6163)
Appropriate
clothing
Skin-to-
skin contact on
day of birth
Bhandari 2012a Cluster RCT 97.5%
(6048/6204)
1.7%
(108/6204)
97.9%
(6036/6163)
0.0%
(2/6163)
CBA: controlled before-after study; IMCI: integrated management of childhood illness; RCT: randomised controlled trial
aA separate team of research assistants interviewed a randomly selected subset of mothers at 29 days to ascertain newborn care practices
bExclusive breast feeding at 4 weeks of life
cChildren < 6 months exclusively breast feeding. Data from baseline and end population surveys
dChildren younger than 4 months exclusively breast fed
eData collected from 2 rounds of district-level health surveys in districts that implemented IMCI in 2005 and in control districts
matched for IMR and proportion of scheduled castes and scheduled tribes. Weighted average of percentage change in coverage levels
calculated for the 2 groups
fChildren aged 6 to 9 months receiving both breast feeding and complementary food. Data from baseline and end population surveys
gInfants who received solid, semi solid, or soft foods in previous 24 hours and started complementary feeding between 6 and 8 months
of age
hNothing or Gentian Violet applied to the cord
A P P E N D I C E S
Appendix 1. Search log and Search strategy for Identification of trials from various databases
Database Date Searched Strategy Hits
The Cochrane Central Regis-
ter of Controlled Trials (CEN-
TRAL)
30 June 2015 (“IMCI”) OR (“IMNCI”) OR (“in-
tegrated management of childhood
illness”) OR (“integrated manage-
ment of childhood illnesses”) in All
28
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(Continued)
fields
EMBASE, Ovid 30 June 2015 (“IMCI”) OR (“IMNCI”) OR (“in-
tegrated management of childhood
illness”) OR (“integrated manage-
ment of childhood illnesses”) in All
fields
468
CINAHL Plus, EbscoHost 30 June 2015 (“IMCI”) OR (“IMNCI”) OR (“in-
tegrated management of childhood
illness”) OR (“integrated manage-
ment of childhood illnesses”) in All
fields
375
LILACS, VHL 30 June 2015 (“IMCI”) OR (“IMNCI”) OR (“in-
tegrated management of childhood
illness”) OR (“integrated manage-
ment of childhood illnesseses”) in All
fields
198
WHOLIS, WHO 30 June 2015 (“IMCI”) OR (“IMNCI”) OR (“in-
tegrated management of childhood
illness”) OR (“integrated manage-
ment of childhood illnesseses”) in All
fields
58
POPLINE 30 June 2015 (“IMCI”) OR (“IMNCI”) in All
fields
427
Science Citation Index and So-
cial SciencesCitation Index, ISI
Web of Science
30 June 2015 (“IMCI”) OR (“IMNCI”) OR (“in-
tegrated management of childhood
illness”) OR (“integrated manage-
ment of childhood illnesses”) in All
fields
544
Global Health, OvidSP 08 May 2015 (IMCI or IMNCI or integrated man-
agement of childhood illness*).af
359
HealthManagement, ProQuest 17 December 2012 (“IMCI”) OR (“IMNCI”) OR (“in-
tegrated management of childhood
illness”) OR (“integrated manage-
ment of childhood illnesseses”) in All
fields
155
MEDLINE, Ovid 30 June 2015 (“IMCI”) OR (“IMNCI”) OR (“in-
tegrated management of childhood
illness”) OR (“integrated manage-
ment of childhood illnesseses”) in All
fields
381
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
“If there are sufficient studies, we also summarised trials with a concurrent comparison group (no IMCI intervention) and adjustment for
baseline characteristics and confounders” - as we found insufficient studies, we did not carry out this analysis. Two outcomes specified in
the protocol were dropped from the review: illness episodes of diarrhoea and pneumonia, as it would be unusual for curative services to
reduce the incidence of disease. One study also reported on other newborn care practices, which we did not anticipate, and we describe
these results under “coverage.”
We specified measures of mortality (neonatal, infant, and under-five mortality) rates and reported on these. We added a measure called
“any mortality” and carried out meta-analysis on the study that reported infant mortality with the study that reported child mortality.
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